10-Q

Large accelerated filer

Accelerated filer

Non-accelerated filer

Smaller reporting company

Emerging growth company

0001193125-20-231322.txt : 20200826 0001193125-20-231322.hdr.sgml : 20200826 20200826163612 ACCESSION NUMBER: 0001193125-20-231322 CONFORMED SUBMISSION TYPE: 10-Q PUBLIC DOCUMENT COUNT: 38 CONFORMED PERIOD OF REPORT: 20200630 FILED AS OF DATE: 20200826 DATE AS OF CHANGE: 20200826 FILER: COMPANY DATA: COMPANY CONFORMED NAME: PTK Acquisition Corp. CENTRAL INDEX KEY: 0001797099 STANDARD INDUSTRIAL CLASSIFICATION: BLANK CHECKS [6770] IRS NUMBER: 842970136 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 10-Q SEC ACT: 1934 Act SEC FILE NUMBER: 001-39377 FILM NUMBER: 201137655 BUSINESS ADDRESS: STREET 1: 100 NORTH AVENUE CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: 6509952208 MAIL ADDRESS: STREET 1: 100 NORTH AVENUE CITY: BOSTON STATE: MA ZIP: 02210 10-Q 1 d87702d10q.htm 10-Q 10-Q

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM 10-Q

☒	QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the quarterly period ended June 30, 2020

☐	TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES

EXCHANGE ACT OF 1934

For the transition period from to

PTK ACQUISITION CORP.

(Exact name of registrant as specified in its charter)

Delaware

001-39377

84-2970136

(State or other jurisdiction of

incorporation or organization)

(Commission

File Number)

(I.R.S. Employer

Identification Number)

4601 Wilshire Boulevard

Suite 240

Los Angeles, California

90010

(Address of principal executive offices)

(Zip Code)

Registrant’s telephone number, including area code: (213) 625-8886

Not Applicable

(Former name or former address, if changed since last report)

Securities registered pursuant to Section 12(b) of the Act:


Title of each class	Trading Symbol(s)	Name of each exchange on which registered
Units, each consisting of one share of Common Stock, and one Warrant to acquire one-half of one share of Common Stock	PTK.U	NYSE American, LLC
Common Stock, par value $0.0001 per share	PTK	NYSE American, LLC
Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50	PTK WS	NYSE American, LLC

Indicate by check mark whether the registrant (1) has filed all reports required to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during the preceding 12 months (or for such shorter period that the registrant was required to file such reports), and (2) has been subject to such filing requirements for the past 90 days. Yes ☐ No ☒

Indicate by check mark whether the registrant has submitted electronically every Interactive Data File required to be submitted pursuant to Rule 405 of Regulation S-T (§ 232.405 of this chapter) during the preceding 12 months (or for such shorter period that the registrant was required to submit such files). Yes ☒ No ☐

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company,” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ☐

Indicate by check mark whether the registrant is a shell company (as defined in Rule 12b-2 of the Exchange Act). Yes ☒ No ☐

As of August 26, 2020, 14,375,000 common stock, par value $0.0001 per share were issued and outstanding.

PTK ACQUISITION CORP.

Form 10-Q

For the Quarter Ended June 30, 2020

Table of Contents


		Page
PART I. FINANCIAL INFORMATION

Item 1.	Financial Statements		1

	Condensed Balance Sheets as of June 30, 2020 (unaudited) and December 31, 2019		1

	Unaudited Condensed Statements of Operations for the three and six months ended June 30, 2020		2

	Unaudited Condensed Statements of Changes in Shareholder’s Equity for the three and six months ended June 30, 2020		3

	Unaudited Condensed Statement of Cash Flows for the six months ended June 30, 2020		4

	Notes to Unaudited Condensed Financial Statements		5

Item 2.	Management’s Discussion and Analysis of Financial Condition and Results of Operations		14

Item 3.	Quantitative and Qualitative Disclosures About Market Risk		17

Item 4.	Controls and Procedures		17

PART II. OTHER INFORMATION

Item 1.	Legal Proceedings		18

Item 1A.	Risk Factors		18

Item 2.	Unregistered Sales of Equity Securities and Use of Proceeds from Registered Securities		18

Item 3.	Defaults Upon Senior Securities		19

Item 4.	Mine Safety Disclosures		19

Item 5.	Other Information		19

Item 6.	Exhibits		19

PART I. FINANCIAL INFORMATION

Item 1.

Financial Statements

PTK ACQUISITION CORP.

CONDENSED BALANCE SHEETS


	June 30, 2020			December 31, 2019
	(unaudited)			(audited)
Assets:
Current assets:
Cash	$	138,048		$	180,975

Total current assets		138,048			180,975
Deferred offering costs associated with the initial public offering		797,481			246,879

Total assets	$	935,529		$	427,854


Liabilities and Stockholder’s Equity (Deficit):
Current liabilities:
Accounts payable	$	394,789		$	103,489
Accrued expenses		223,146			—
Franchise tax payable		102,253			2,202
Note payable - related party		300,000			300,000

Total current liabilities		1,020,188			405,691


Commitments and Contingencies

Stockholder’s Equity:
Common stock, $0.0001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding (1)		288			288
Additional paid-in capital		24,712			24,712
Accumulated deficit		(109,659	)		(2,837	)

Total stockholder’s equity (deficit)		(84,659	)		22,163

Total liabilities and stockholder’s equity (deficit)	$	935,529		$	427,854

(1) This number includes up to 375,000 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited.

The accompanying notes are an integral part of these unaudited condensed financial statements.

PTK ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF OPERATIONS


	For the Three Months Ended June 30, 2020			For the Six Months Ended June 30, 2020
General and administrative expenses	$	202		$	6,771
Franchise tax expense		98,028			100,051

Net loss	$	(98,230	)	$	(106,822	)


Weighted average shares outstanding, basic and diluted⁽¹⁾		2,500,000			2,500,000


Basic and diluted net loss per share	$	(0.04	)	$	(0.04	)

(1) This number excludes an aggregate of up to 375,000 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited.

The accompanying notes are an integral part of these unaudited condensed financial statements.

PTK ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENTS OF CHANGES IN SHAREHOLDER’S EQUITY


	For the Three and Six Months Ended June 30, 2020
	Common Stock				Additional Paid-In Capital		Accumulated Deficit			Total Stockholder’s Equity (Deficit)
	Common Stock
	Shares (1)		Amount
Balance - December 31, 2019 (audited)		2,875,000		288		24,712		(2,837	)		22,163
Net loss		—		—		—		(8,592	)		(8,592	)

Balance - March 31, 2020 (unaudited)		2,875,000		288		24,712		(11,429	)		13,571
Net loss		—		—		—		(98,230	)		(98,230	)

Balance - June 30, 2020 (unaudited)		2,875,000	$	288	$	24,712	$	(109,659	)	$	(84,659	)

The accompanying notes are an integral part of these unaudited condensed financial statements.

PTK ACQUISITION CORP.

UNAUDITED CONDENSED STATEMENT OF CASH FLOWS


	For the Six Months Ended June 30, 2020
Cash Flows from Operating Activities:
Net loss	$	(106,822	)
Changes in operating assets and liabilities:
Accounts payable		6,771
Franchise tax payable		100,051

Net cash used in operating activities		—


Cash Flows from Financing Activities:
Deferred offering costs paid		(42,927	)

Net cash used in financing activities		(42,927	)


Net change in cash		(42,927	)

Cash - beginning of the period		180,975

Cash - end of the period	$	138,048


Supplemental disclosure of noncash activities:
Deferred offering costs included in accounts payable	$	309,707
Deferred offering costs included in accrued expenses	$	223,146

The accompanying notes are an integral part of these unaudited condensed financial statements.

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 1 — Description of Organization and Business Operations

PTK Acquisition Corp. (the “Company”) was incorporated in Delaware on August 19, 2019. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies.

As of June 30, 2020, the Company had not commenced any operations. All activity for the period from August 19, 2019 (inception) through June 30, 2020 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company will generate non-operating income in the form of interest income on investments held in trust from the proceeds derived from the Initial Public Offering and the sale of the Private Placement Warrants (as defined below). The Company has selected December 31 as its fiscal year end.

The Company’s sponsor is PTK Holdings LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on July 13, 2020. On July 15, 2020, the Company consummated the Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the common stock included in the Units, the “Public Shares”), including the issuance of 1,500,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $115.0 million, and incurring offering costs of approximately $7.3 million, inclusive of approximately $4.0 million in deferred underwriting commissions (Note 5).

Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,800,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $0.50 per Private Placement Warrant to the Sponsor, generating gross proceeds to the Company of $3.4 million (Note 4).

Upon the closing of the Initial Public Offering and the Private Placement, $115.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations, until the distribution of the Trust Account as described below.

The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the Trust Account) at the time of signing the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”).

The Company will provide its holders (the “Public Stockholders”) of its common stock, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share), calculated as of two business

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

days prior to the consummation of a Business Combination, including interest (which interest shall be net of taxes payable). The per-share amount to be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon consummation of the Business Combination and a majority of the Company’s common stock voted at the applicable meeting are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and the Company’s officers and directors have agreed to vote any Insider Shares (as defined below in Note 4) and Public Shares held by them in favor of a Business Combination. In addition, the Sponsor and the Company’s officers and directors have agreed to waive their redemption rights with respect to any Public Shares held by them in connection with the completion of a Business Combination.

Notwithstanding the foregoing redemption rights, if the Company seeks stockholder approval of its initial Business Combination and the Company does not conduct redemptions in connection with its initial Business Combination pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the shares sold in the Initial Public Offering, without the prior consent of the Company.

The Sponsor and the Company’s officers and directors agreed not to propose any amendment to the Company’s Amended and Restated Certificate of Incorporation (1) to modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of the Initial Public Offering, or January 15, 2022 (the “Combination Period”) or (2) which adversely affects the rights of holders of the Public Shares, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares upon approval of any such amendment.

If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares for a pro rata portion of the funds held in the Trust Account (net of interest that may be used by the Company to pay income taxes or other taxes) which redemption will completely extinguish the Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining holders of common stock and the Company’s board of directors, dissolve and liquidate, subject (in the case of (ii) and (iii) above) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Company will pay the costs of any liquidation following the redemptions from its remaining assets outside of the Trust Account. If such funds are insufficient, the Sponsor has agreed to pay the funds necessary to complete such liquidation (currently anticipated to be no more than approximately $50,000) and has agreed not to seek repayment for such expenses.

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account, or less than such amount in certain circumstances. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including, but not limited to, all vendors, service providers (excluding its independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of the Public Stockholders.

Liquidity and Capital Resources

As of June 30, 2020, the Company had approximately $138,000 in its operating bank accounts, working capital deficit of approximately $780,000.

Prior to the completion of the Initial Public Offering on July 15, 2020, the Company’s liquidity needs were satisfied through the receipt of $25,000 from the Sponsor in exchange for the issuance of the Founder Shares, and a $300,000 Note issued to the Sponsor, which was converted in to private warrants upon closing of the Initial Public Offering (Note 4). Subsequent to the consummation of the Initial Public Offering and Private Placement in July 2020, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). To date, there were no amounts outstanding under any Working Capital Loans.

Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the “COVID-19 outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020.

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form 8-K and the final prospectus filed by the Company with the SEC on July 21, 2020 and July 15, 2020, respectively.

Emerging Growth Company

Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that apply to non-emerging growth companies but any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used.

Concentration of Credit Risk

Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts.

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of June 30, 2020.

Financial Instruments

The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurement” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature.

Use of Estimates

The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates.

Deferred Offering Costs Associated with the Initial Public Offering

Deferred offering costs consist of legal, accounting, underwriting fees and other costs through the balance sheet date that were directly related to the Initial Public Offering and that were charged to stockholders’ equity upon the completion of the Initial Public Offering.

Net Loss Per Share of Common Stock

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

common stock outstanding during the period excluding shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 375,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited. At June 30, 2020 and December 31, 2019, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented.

Income Taxes

The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of June 30, 2020.

FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception.

The provision for income taxes was deemed to be immaterial as of June 30, 2020.

Recent Accounting Standards

The Company’s management does not believe that there are any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements.

Note 3 — Initial Public Offering

On July 15, 2020, the Company consummated the Initial Public Offering of 11,500,000 Units, including the issuance of 1,500,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $115.0 million, and incurring offering costs of approximately $7.3 million, inclusive of approximately $4.0 million in deferred underwriting commissions. Each Unit consists of one share of common stock and one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to purchase one-half (1/2) of one share of common stock at a price of $11.50 per whole share, subject to adjustment (see Note 6).

Of the 11,500,000 Units sold in the Initial Public Offering, an aggregate of 1,000,000 Units were purchased by Primerose Development Group Ltd. (“Primerose”). Primerose also entered into an agreement with the Company providing that it will hold at least 1,000,000 shares of the Company’s common stock following the Initial Business Combination. Primerose’s commitment to hold at least 1,000,000 shares of the Company’s common stock following the Initial Business Combination was satisfied by a purchase of Units in the Initial Public Offering.

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 4 — Related Party Transactions

Insider Shares

In October 2019, the Sponsor purchased 2,875,000 shares of common stock, par value $0.0001, (the “Insider Shares”), for an aggregate price of $25,000. The Sponsor has agreed to forfeit up to 375,000 Insider Shares to the extent that the over-allotment option is not exercised in full by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, no Insider Shares were forfeited.

The Sponsor and the Company’s officers and directors agreed to place their Insider Shares into an escrow account maintained by Continental Stock Transfer & Trust Company, acting as escrow agent. Subject to certain limited exceptions, 50% of these shares will not be transferred, assigned, sold or released from escrow until the earlier of six months after the date of the consummation of the initial Business Combination and the date on which the closing price of the Company’s common stock equals or exceeds $12.50 per share (as adjusted for stock splits, stock dividends, reorganizations and recapitalizations) for any 20 trading days within any 30-trading day period commencing after the consummation of the initial Business Combination and the remaining 50% of the Insider Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of the initial Business Combination, or earlier, in either case, if, subsequent to the initial Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. The limited exceptions referred to above include (1) transfers among the insiders, to the Company’s officers, directors, advisors and employees, (2) transfers to an insider’s affiliates or its members upon its liquidation, (3) transfers to relatives and trusts for estate planning purposes, (4) transfers by virtue of the laws of descent and distribution upon death, (5) transfers pursuant to a qualified domestic relations order, (6) private sales made at prices no greater than the price at which the securities were originally purchased or (7) transfers to the Company for cancellation in connection with the consummation of an initial Business Combination, in each case (except for clause 7) where the transferee agrees to the terms of the escrow agreement and forfeiture, as the case may be, as well as the other applicable restrictions and agreements of the holders of the Insider Shares.

Private Placement Warrants

Simultaneously with the closing of the Initial Public Offering, the Sponsor purchased an aggregate of 6,800,000 Private Placement Warrants, at a price of $0.50 per Private Placement Warrant to the Sponsor, generating gross proceeds to the Company of $3.4 million. A portion of the proceeds from the Private Placement Units were added to the proceeds from the Initial Public Offering held in the Trust Account. If the Company does not complete a Business Combination within the Combination Period, the Private Placement Warrants will expire worthless.

Related Party Loans

On October 10, 2019, the Sponsor agreed to loan the Company an aggregate of up to $300,000 to cover expenses related to the Initial Public Offering pursuant to a promissory note (the “Note”). This loan was non-interest bearing, and on July 9, 2020 the Company amended such loan to provide that such loan: (A) was convertible into 600,000 private warrants issuable to the Sponsor at a purchase price of $0.50 per warrant upon the consummation of the Initial Public Offering; or (B) due in cash to the Sponsor on the date the Company determines not to proceed with the Initial Public Offering. The Company fully borrowed the Note amount of $300,000 as of June 30, 2020. The Note was converted into 600,000 private warrants upon the consummation of the Initial Public Offering on July 15, 2020.

In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but is not obligated to, loan the Company funds as may be required (“Working Capital Loans”). If the Company completes a Business Combination, the Company may repay the Working Capital Loans out of the proceeds of the Trust Account released to the Company. Otherwise, the Working Capital Loans may be repaid only out of funds held outside the Trust Account. In the event that a Business Combination does not close, the Company may use a portion of proceeds held outside the Trust Account to repay the Working Capital Loans but no proceeds held in the Trust Account would be used to repay the Working Capital Loans. The Working Capital Loans would either be repaid upon consummation of a Business Combination, without interest, or, at the Sponsor’s discretion, up to $1,000,000 of such Working Capital Loans may be convertible into private placement warrants at a price of $0.50 per warrant. Except for the foregoing, the terms of such Working Capital Loans, if any, have not been determined and no written agreements exist with respect to such loans. To date, the Company had no borrowings under the Working Capital Loans.

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Administrative Support Agreement

The Company may enter into an agreement to pay the Sponsor a total of up to $10,000 per month for overhead and administration support. Upon completion of the Initial Business Combination or the Company’s liquidation, the Company will cease paying these monthly fees.

Note 5 — Commitments & Contingencies

Registration Rights

The holders of Insider Shares, Private Placement Warrants, and warrants that may be issued upon conversion of Working Capital Loans, if any, will be entitled to registration rights pursuant to a registration rights agreement. These holders will be entitled to certain demand and “piggyback” registration rights.

Underwriting Agreement

The Company granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised their over-allotment option on July 15, 2020.

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $2.3 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $4.025 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee is payable to the underwriters from the amounts held in the Trust Account solely in the event that the Company completes a Business Combination, subject to the terms of the underwriting agreement.

Right of First Refusal

Subject to certain conditions, the Company granted Chardan, for a period of 15 months after the date of the consummation of the Business Combination, a right of first refusal to act as either (at the Company’s sole discretion) (a) a lead underwriter or (b) minimally as a co-manager, with at least 30% of the economics; or, in the case of a three-handed deal 20% of the economics, for any and all future public and private equity and debt offerings. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statement related to the Initial Public Offering.

Note 6 — Stockholder’s Equity

Common stock — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of common stock are entitled to one vote for each share held on all matters to be voted on by stockholders. As of June 30, 2020 and December 31, 2019, there were 2,875,000 shares of common stock outstanding. Of the 2,875,000 shares of common stock, an aggregate of up to 375,000 shares are subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so as to maintain the number of Insider Shares at 20% of the Company’s issued and outstanding common stock after the Proposed Public Offering. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, no Insider Shares were forfeited.

Warrants — The Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination and (b) 12 months from the closing of the Proposed Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the common stock issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement). Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective within 90 days from the consummation of the initial Business Combination, warrant holders may, until

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

such time as there is an effective registration statement and during any period when the Company has failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act provided that such exemption is available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the shares of common stock for the 10 trading days ending on the day prior to the date of exercise.

The warrants are exercisable at $11.50 per whole share, subject to adjustment, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination, and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Price”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the Market Value.

The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Proposed Public Offering, except that the Private Placement Warrants and the common stock issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Common stock issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants.

The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption;

•

if, and only if, the last reported sale price of the Common stock equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within a 30-trading day period ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and

•

if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and for the entire 30-day trading period referred to above and continuing each day thereafter until the date of redemption.

If the Company calls the Public Warrants for redemption as described above, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement.

Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless.

PTK ACQUISITION CORP.

NOTES TO UNAUDITED CONDENSED FINANCIAL STATEMENTS

Note 7 — Subsequent Events

The Company evaluated subsequent events and transactions that occurred up to the date unaudited condensed financial statements were available to be issued. Based upon this review, the Company determined that there have been no events that have occurred that would require adjustments to the disclosures in the unaudited condensed financial statements.

Item 2. Management’s Discussion and Analysis of Financial Condition and Results of Operations.

References to the “Company,” “PTK Acquisition Corp.,” “our,” “us” or “we” refer to PTK Acquisition Corp. The following discussion and analysis of the Company’s financial condition and results of operations should be read in conjunction with the unaudited interim condensed financial statements and the notes thereto contained elsewhere in this report. Certain information contained in the discussion and analysis set forth below includes forward-looking statements that involve risks and uncertainties.

Cautionary Note Regarding Forward-Looking Statements

This Quarterly Report on Form 10-Q includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Exchange Act. We have based these forward-looking statements on our current expectations and projections about future events. These forward-looking statements are subject to known and unknown risks, uncertainties and assumptions about us that may cause our actual results, levels of activity, performance or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by such forward-looking statements. In some cases, you can identify forward-looking statements by terminology such as “may,” “should,” “could,” “would,” “expect,” “plan,” “anticipate,” “believe,” “estimate,” “continue,” or the negative of such terms or other similar expressions. Factors that might cause or contribute to such a discrepancy include, but are not limited to, those described in our other SEC filings.

Overview

We are a blank check company incorporated in Delaware on August 19, 2019. We were formed for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”).

Our sponsor is PTK Holdings LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the initial public offering (the “Initial Public Offering”) was declared effective on July 13, 2020. On July 15, 2020, we consummated the Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the common stock included in the Units, the “Public Shares”), including the issuance of 1,500,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $115.0 million, and incurring offering costs of approximately $7.3 million, inclusive of approximately $4.0 million in deferred underwriting commissions.

Simultaneously with the closing of the Initial Public Offering, we consummated the private placement (“Private Placement”) of 6,800,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $0.50 per Private Placement Warrant to our Sponsor, generating gross proceeds to the Company of $3.4 million.

Our management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination.

If we are unable to complete a Business Combination within 18 months from the closing of the Initial Public Offering, or January 15, 2022 (the “Combination Period”), we will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares for a pro rata portion of the funds held in the Trust Account (net of interest that may be used by us to

pay income taxes or other taxes) which redemption will completely extinguish the public stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of our remaining holders of common stock and our board of directors, dissolve and liquidate, subject (in the case of (ii) and (iii) above) to our obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. We will pay the costs of any liquidation following the redemptions from our remaining assets outside of the Trust Account. If such funds are insufficient, our Sponsor has agreed to pay the funds necessary to complete such liquidation (currently anticipated to be no more than approximately $50,000) and has agreed not to seek repayment for such expenses.

Liquidity and Capital Resources

As of June 30, 2020, we had approximately $138,000 in its operating bank accounts, working capital deficit of approximately $780,000.

Prior to the completion of the Initial Public Offering in July 2020, our liquidity needs were satisfied through the receipt of $25,000 from our Sponsor in exchange for the issuance of the founder shares, and a $300,000 promissory note issued to our Sponsor, which was converted in to private warrants upon closing of the Initial Public Offering. Subsequent to the consummation of the Initial Public Offering and Private Placement on July 15, 2020, our liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, our Sponsor may, but are not obligated to, provide us Working Capital Loans. To date, there were no amounts outstanding under any Working Capital Loans.

Based on the foregoing, our management believes that we will have sufficient working capital and borrowing capacity to meet our needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, we will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination.

Management continues to evaluate the impact of the COVID-19 pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

Results of Operations

Our entire activity since inception up to June 30, 2020 was in preparation for our formation and the Initial Public Offering. We will not be generating any operating revenues until the closing and completion of our initial Business Combination.

For the three months ended June 30, 2020, we had net loss of approximately $98,200, which consisted of approximately $200 in general and administrative expenses, and approximately $98,000 in franchise tax expense.

For the six months ended June 30, 2020, we had net loss of approximately $106,800, which consisted of approximately $6,800 in general and administrative expenses, and approximately $100,000 in franchise tax expense.

Contractual Obligations

Administrative Support Agreement

We may enter into an agreement to pay our Sponsor a total of up to $10,000 per month for overhead and administration support. Upon completion of the Initial Business Combination or our liquidation, we will cease paying these monthly fees.

Registration Rights

Underwriting Agreement

We granted the underwriters a 45-day option from the final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised their over-allotment option on July 15, 2020.

The underwriters were entitled to an underwriting discount of $0.20 per unit, or $2.3 million in the aggregate, paid upon the closing of the Initial Public Offering. In addition, $0.35 per unit, or $4.025 million in the aggregate will be payable to the underwriters for deferred underwriting commissions. The deferred fee is payable to the underwriters from the amounts held in the Trust Account solely in the event that we complete a Business Combination, subject to the terms of the underwriting agreement.

Right of First Refusal

Subject to certain conditions, we granted Chardan, for a period of 15 months after the date of the consummation of the Business Combination, a right of first refusal to act as either (at our sole discretion) (a) a lead underwriter or (b) minimally as a co-manager, with at least 30% of the economics; or, in the case of a three-handed deal 20% of the economics, for any and all future public and private equity and debt offerings. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statement related to the Initial Public Offering.

Critical Accounting Policies

Deferred Offering Costs Associated with the Initial Public Offering

Net Loss Per Share of Common Stock

We comply with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share of common stock is computed by dividing net loss by the weighted average number of common stock outstanding during the period excluding shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 375,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited. At June 30, 2020 and December 31, 2019, we did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented.

Recent Accounting Standards

Our management does not believe that there are any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on our condensed financial statements.

Off-Balance Sheet Arrangements

As of June 30, 2020, we did not have any off-balance sheet arrangements as defined in Item 303(a)(4)(ii) of Regulation S-K.

JOBS Act

The Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) contains provisions that, among other things, relax certain reporting requirements for qualifying public companies. We qualify as an “emerging growth company” and under the JOBS Act are allowed to comply with new or revised accounting pronouncements based on the effective date for private (not publicly traded) companies. We are electing to delay the adoption of new or revised accounting standards, and as a result, we may not comply with new or revised accounting standards on the relevant dates on which adoption of such standards is required for non-emerging growth companies. As a result, the financial statements may not be comparable to companies that comply with new or revised accounting pronouncements as of public company effective dates.

Additionally, we are in the process of evaluating the benefits of relying on the other reduced reporting requirements provided by the JOBS Act. Subject to certain conditions set forth in the JOBS Act, if, as an “emerging growth company,” we choose to rely on such exemptions we may not be required to, among other things, (i) provide an auditor’s attestation report on our system of internal controls over financial reporting pursuant to Section 404, (ii) provide all of the compensation disclosure that may be required of non-emerging growth public companies under the Dodd-Frank Wall Street Reform and Consumer Protection Act, (iii) comply with any requirement that may be adopted by the PCAOB regarding mandatory audit firm rotation or a supplement to the auditor’s report providing additional information about the audit and the financial statements (auditor discussion and analysis) and (iv) disclose certain executive compensation related items such as the correlation between executive compensation and performance and comparisons of the CEO’s compensation to median employee compensation. These exemptions will apply for a period of five years following the completion of our Initial Public Offering or until we are no longer an “emerging growth company,” whichever is earlier.

Item 3. Quantitative and Qualitative Disclosures About Market Risk

We are a smaller reporting company as defined by Rule 12b-2 of the Exchange Act and are not required to provide the information otherwise required under this item. As of June 30, 2020, we were not subject to any market or interest rate risk. The net proceeds of the Initial Public Offering, including amounts in the Trust Account, will be invested in U.S. government securities within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. Due to the short-term nature of these investments, we believe there will be no associated material exposure to interest rate risk.

We have not engaged in any hedging activities since our inception and we do not expect to engage in any hedging activities with respect to the market risk to which we are exposed.

Item 4. Controls and Procedures

Evaluation of Disclosure Controls and Procedures

Under the supervision and with the participation of our management, including our principal executive officer and principal financial officer, we conducted an evaluation of the effectiveness of our disclosure controls and procedures as of the end of the fiscal quarter ended June 30, 2020, as such term is defined in Rules 13a-15(e) and 15d-15(e) under the Exchange Act. Based on this evaluation, our principal executive officer and principal financial officer has concluded that during the period covered by this report, our disclosure controls and procedures were effective.

Disclosure controls and procedures are designed to ensure that information required to be disclosed by us in our Exchange Act reports is recorded, processed, summarized, and reported within the time periods specified in the SEC’s rules and forms, and that such information is accumulated and communicated to our management, including our principal executive officer and principal financial officer or persons performing similar functions, as appropriate to allow timely decisions regarding required disclosure.

Changes in Internal Control over Financial Reporting

There was no change in our internal control over financial reporting that occurred during the fiscal quarter ended June 30, 2020 covered by this Quarterly Report on Form 10-Q that has materially affected, or is reasonably likely to materially affect, our internal control over financial reporting.

PART II - OTHER INFORMATION

Item 1. Legal Proceedings

None.

Item 1A. Risk Factors

As of the date of this Quarterly Report on Form 10-Q, there have been no material changes to the risk factors disclosed in our final prospectus filed with the SEC on July 15, 2020, except for the below risk factor. We may disclose changes to such factors or disclose additional factors from time to time in our future filings with the SEC.

The securities in which we invest the funds held in the trust account could bear a negative rate of interest, which could reduce the value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.00 per share.

The proceeds held in the trust account will be invested only in U.S. government treasury obligations within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions under Rule 2a-7 promulgated under the Investment Company Act which invest only in direct U.S. government treasury obligations. While short-term U.S. government treasury obligations currently yield a positive rate of interest, they have briefly yielded negative interest rates in recent years. Central banks in Europe and Japan pursued interest rates below zero in recent years, and the Open Market Committee of the Federal Reserve has not ruled out the possibility that it may in the future adopt similar policies in the United States. In the event that we are unable to complete our initial business combination or make certain amendments to our amended and restated memorandum and articles of association, our public shareholders are entitled to receive their pro-rata share of the proceeds held in the trust account, plus any interest income, net of income taxes paid or payable (less, in the case we are unable to complete our initial business combination, $50,000 of interest to pay dissolution expenses). Negative interest rates could reduce the value of the assets held in trust such that the per-share redemption amount received by public shareholders may be less than $10.00 per share.

Item 2. Unregistered Sales of Equity Securities and Use of Proceeds.

Simultaneously with the consummation of the Initial Public Offering and the exercise of the over-allotment option by the underwriters in full, our Sponsor purchased 6,800,000 Private Placement Warrants, at a price of $0.50 per Private Placement Warrant, generating gross proceeds to us of $3.4 million. This issuance was made pursuant to the exemption from registration contained in Section 4(a)(2) of the Securities Act and no underwriting discounts or commissions were paid with respect to such sale.

In connection with the Initial Public Offering, our Sponsor had agreed to loan us an aggregate of up to $300,000 pursuant to the Note. This loan was non-interest bearing, and on July 9, 2020 we amended such loan to provide that such loan: (A) was convertible into 600,000 private warrants issuable to our Sponsor at a purchase price of $0.50 per warrant upon the consummation of the Initial Public Offering; or (B) due in cash to our Sponsor on the date we determine not to proceed with the Initial Public Offering. We fully borrowed the Note amount of $300,000 as of June 30, 2020. The Note was converted into 600,000 private warrants upon the consummation of the Initial Public Offering on July 15, 2020.

Of the gross proceeds received from the Initial Public Offering and the full exercise of the option to purchase additional Units, $115.0 million ($10.00 per Unit) was placed in the Trust Account. The net proceeds of the Initial Public Offering and certain proceeds from the sale of the Private Placement Warrants are invested in U.S. government treasury bills with a maturity of 180 days or less and in money market funds meeting certain conditions under Rule 2a-7 under the Investment Company Act which invest only in direct U.S. government treasury obligations.

We paid a total of $2.3 million in underwriting discounts and commissions and approximately $973,000 for other costs and expenses related to the Initial Public Offering. In addition, the underwriters agreed to defer approximately $4.0 million in underwriting discounts and commissions.

Item 3. Defaults upon Senior Securities

None.

Item 4. Mine Safety Disclosures.

Not applicable.

Item 5. Other Information.

Number and Terms of Directors

Our board of directors currently has six members, three of whom are deemed “independent” under SEC and New York Stock Exchange rules.

Pursuant to our Amended and Restated Certificate of Incorporation, our board of directors shall be divided into three classes, with only one class of directors being appointed in each year, and with each class (except for those directors appointed prior to our first annual general meeting) serving a three-year term. The term of office of Class I of directors, consisting of John Hui and Charles Huang, will expire at our first general annual meeting. The term of office of the Class II of directors, consisting of Dr. Walden C. Rhines and Timothy Chen, will expire at our second annual general meeting. The term of office of the Class III of directors, consisting of Peter Kuo and Ker Zhang, will expire at our third annual general meeting.

Item 6. Exhibits.


Exhibit Number		Description

31.1*		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

31.2*		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to Rules 13a-14(a) and 15d-14(a) under the Securities Exchange Act of 1934, as Adopted Pursuant to Section 302 of the Sarbanes-Oxley Act of 2002.

32.1*		Certification of Chief Executive Officer (Principal Executive Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

32.2*		Certification of Chief Financial Officer (Principal Financial and Accounting Officer) Pursuant to 18 U.S.C. Section 1350, as Adopted Pursuant to Section 906 of the Sarbanes-Oxley Act of 2002.

101.INS		XBRL Instance Document

101.SCH		XBRL Taxonomy Extension Schema Document

101.CAL		XBRL Taxonomy Extension Calculation Linkbase Document

101.DEF		XBRL Taxonomy Extension Definition Linkbase Document

101.LAB		XBRL Taxonomy Extension Label Linkbase Document

101.PRE		XBRL Taxonomy Extension Presentation Linkbase Document

These certifications are furnished to the SEC pursuant to Section 906 of the Sarbanes-Oxley Act of 2002 and are deemed not filed for purposes of Section 18 of the Securities Exchange Act of 1934, as amended, nor shall they be deemed incorporated by reference in any filing under the Securities Act of 1933, except as shall be expressly set forth by specific reference in such filing.

SIGNATURE

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

Dated: August 26, 2020


PTK ACQUISITION CORP.

By:		/s/ Timothy Chen
Name:		Timothy Chen
Title:		Chief Financial Officer

EX-31.1 2 d87702dex311.htm EX-31.1 EX-31.1

EXHIBIT 31.1

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Peter Kuo, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 of PTK Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and and 15d-15(e)) for the registrant and have:

Designed such disclosure controls and procedures, or caused such disclosure controls and procedures to be designed under our supervision, to ensure that material information relating to the registrant, including its consolidated subsidiaries, is made known to us by others within those entities, particularly during the period in which this report is being prepared;

[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

Evaluated the effectiveness of the registrant’s disclosure controls and procedures and presented in this report our conclusions about the effectiveness of the disclosure controls and procedures, as of the end of the period covered by this report based on such evaluation; and

Disclosed in this report any change in the registrant’s internal control over financial reporting that occurred during the registrant’s most recent fiscal quarter (the registrant’s fourth fiscal quarter in the case of an annual report) that has materially affected, or is reasonably likely to materially affect, the registrant’s internal control over financial reporting; and

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

All significant deficiencies and material weaknesses in the design or operation of internal control over financial reporting which are reasonably likely to adversely affect the registrant’s ability to record, process, summarize and report financial information; and

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

EX-31.2 3 d87702dex312.htm EX-31.2 EX-31.2

EXHIBIT 31.2

CERTIFICATION

PURSUANT TO RULES 13a-14(a) AND 15d-14(a)

UNDER THE SECURITIES EXCHANGE ACT OF 1934, AS ADOPTED PURSUANT TO

SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002

I, Timothy Chen, certify that:

1.	I have reviewed this Quarterly Report on Form 10-Q for the quarter ended June 30, 2020 of PTK Acquisition Corp.;

2.	Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of the circumstances under which such statements were made, not misleading with respect to the period covered by this report;

3.	Based on my knowledge, the financial statements, and other financial information included in this report, fairly present in all material respects the financial condition, results of operations and cash flows of the registrant as of, and for, the periods presented in this report;

4.	The registrant’s other certifying officers and I are responsible for establishing and maintaining disclosure controls and procedures (as defined in Exchange Act Rules 13a-15(e) and and 15d-15(e)) for the registrant and have:

[Paragraph omitted pursuant to SEC Release Nos. 33-8238/34-47986 and 33-8392/34-49313];

5.	The registrant’s other certifying officers and I have disclosed, based on our most recent evaluation of internal control over financial reporting, to the registrant’s auditors and the audit committee of the registrant’s board of directors (or persons performing the equivalent functions):

Any fraud, whether or not material, that involves management or other employees who have a significant role in the registrant’s internal controls over financial reporting.

EX-32.1 4 d87702dex321.htm EX-32.1 EX-32.1

EXHIBIT 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PTK Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Peter Kuo, Chief Executive Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 26, 2020


/s/ Peter Kuo
Name:		Peter Kuo
Title:		Chief Executive Officer
		(Principal Executive Officer)

EX-32.2 5 d87702dex322.htm EX-32.2 EX-32.2

EXHIBIT 32.2

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of PTK Acquisition Corp. (the “Company”) on Form 10-Q for the quarter ended June 30, 2020, as filed with the Securities and Exchange Commission on the date hereof (the “Report”), I, Timothy Chen, Chief Financial Officer of the Company, certify, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that, to my knowledge:

(1)	the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2)	the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.

Date: August 26, 2020


/s/ Timothy Chen
Name:		Timothy Chen
Title:		Chief Financial Officer
		(Principal Financial and Accounting Officer)

EX-101.INS 6 ptk-20200630.xml XBRL INSTANCE DOCUMENT 0001797099 2020-01-01 2020-06-30 0001797099 2020-06-30 0001797099 2019-12-31 0001797099 2020-04-01 2020-06-30 0001797099 2020-01-01 2020-03-31 0001797099 2020-06-30 2020-06-30 0001797099 2019-10-31 0001797099 2020-07-15 0001797099 2020-08-26 0001797099 2020-03-31 0001797099 us-gaap:WarrantMember 2020-01-01 2020-06-30 0001797099 us-gaap:CapitalUnitsMember 2020-01-01 2020-06-30 0001797099 us-gaap:CommonStockMember 2020-01-01 2020-06-30 0001797099 ptk:PrivatePlacementWarrantsMember 2020-01-01 2020-06-30 0001797099 ptk:SponsorMember 2020-01-01 2020-06-30 0001797099 us-gaap:IPOMember 2020-01-01 2020-06-30 0001797099 us-gaap:IPOMember 2020-06-30 0001797099 ptk:PrivatePlacementWarrantsMember 2020-06-30 0001797099 ptk:WorkingCapitalLoanMember 2020-06-30 0001797099 ptk:SponsorMember ptk:NoteMember 2020-06-30 0001797099 srt:MaximumMember 2020-06-30 0001797099 us-gaap:RetainedEarningsMember 2020-04-01 2020-06-30 0001797099 us-gaap:RetainedEarningsMember 2020-01-01 2020-03-31 0001797099 us-gaap:OverAllotmentOptionMember 2020-06-30 2020-06-30 0001797099 us-gaap:IPOMember 2020-06-30 2020-06-30 0001797099 ptk:PrimeroseMember us-gaap:IPOMember 2020-06-30 2020-06-30 0001797099 ptk:SponsorMember 2019-10-31 2019-10-31 0001797099 us-gaap:OverAllotmentOptionMember 2019-10-31 2019-10-31 0001797099 ptk:SponsorMember 2019-10-31 0001797099 ptk:SponsorMember ptk:NoteMember 2019-10-10 0001797099 ptk:NoteMember srt:ScenarioForecastMember 2020-07-09 2020-07-09 0001797099 ptk:NoteMember srt:ScenarioForecastMember 2020-07-09 0001797099 ptk:NoteMember us-gaap:SubsequentEventMember 2020-07-15 2020-07-15 0001797099 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-07-15 2020-07-15 0001797099 us-gaap:CommonClassAMember us-gaap:OverAllotmentOptionMember 2020-07-15 2020-07-15 0001797099 us-gaap:IPOMember 2020-07-15 2020-07-15 0001797099 us-gaap:OverAllotmentOptionMember 2020-07-15 2020-07-15 0001797099 us-gaap:CommonClassAMember us-gaap:IPOMember 2020-07-15 0001797099 us-gaap:IPOMember 2020-07-15 0001797099 us-gaap:CommonStockMember 2020-06-30 0001797099 us-gaap:AdditionalPaidInCapitalMember 2020-06-30 0001797099 us-gaap:RetainedEarningsMember 2020-06-30 0001797099 us-gaap:CommonStockMember 2019-12-31 0001797099 us-gaap:AdditionalPaidInCapitalMember 2019-12-31 0001797099 us-gaap:RetainedEarningsMember 2019-12-31 0001797099 us-gaap:CommonStockMember 2020-03-31 0001797099 us-gaap:AdditionalPaidInCapitalMember 2020-03-31 0001797099 us-gaap:RetainedEarningsMember 2020-03-31 10-Q false 2020 Q2 2020-06-30 --12-31 false true PTK Acquisition Corp. 0001797099 Non-accelerated Filer No Yes 14375000 NYSE NYSE NYSE true false true true

138048

180975

138048

180975

797481

246879

935529

427854

394789

103489

223146

102253

300000

1020188

405691

2202

288

24712

-109659

-2837

-84659

22163

935529

427854

0.0001

100000000

2875000

375000

202

6771

98028 100051

-98230

-106822

2500000

-0.04

<div style="font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 7 — Subsequent Events </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company evaluated subsequent events and transactions that occurred up to the date unaudited condensed financial statements were available to be issued. Based upon this review, the Company determined that there have been no events that have occurred that would require adjustments to the disclosures in the unaudited condensed financial statements. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 6 — Stockholder’s Equity </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Common stock</div></div> — The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of common stock are entitled to one vote for each share held on all matters to be voted on by stockholders. As of June 30, 2020 and December 31, 2019, there were 2,875,000 shares of common stock outstanding. Of the 2,875,000 shares of common stock, an aggregate of up to 375,000 shares are subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so as to maintain the number of Insider Shares at 20% of the Company’s issued and outstanding common stock after the Proposed Public Offering. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, no Insider Shares were forfeited. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Warrants</div></div> — The Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination and (b) 12 months from the closing of the Proposed Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the common stock issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement). Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective within 90 days from the consummation of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company has failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act provided that such exemption is available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the shares of common stock for the 10 trading days ending on the day prior to the date of exercise. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The warrants are exercisable at $11.50 per whole share, subject to adjustment, and will expire five years after the completion of a Business Combination or earlier upon redemption or liquidation. In addition, if (x) the Company issues additional shares of common stock or equity-linked securities for capital raising purposes in connection with the closing of the initial Business Combination at an issue price or effective issue price of less than $9.50 per share of common stock (with such issue price or effective issue price to be determined in good faith by the Company’s board of directors), (y) the aggregate gross proceeds from such issuances represent more than 60% of the total equity proceeds, and interest thereon, available for the funding of the initial Business Combination, and (z) the volume weighted average trading price of the Company’s common stock during the 20 trading day period starting on the trading day prior to the day on which the Company consummates its initial Business Combination (such price, the “Market Price”) is below $9.50 per share, the exercise price of the warrants will be adjusted (to the nearest cent) to be equal to 115% of the Market Price, and the $18.00 per share redemption trigger price described above will be adjusted (to the nearest cent) to be equal to 180% of the Market Value. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Private Placement Warrants are identical to the Public Warrants underlying the Units sold in the Proposed Public Offering, except that the Private Placement Warrants and the common stock issuable upon exercise of the Private Placement Warrants, so long as they are held by the Sponsor or its permitted transferees, (i) will not be redeemable by the Company, (ii) may not (including the Common stock issuable upon exercise of these warrants), subject to certain limited exceptions, be transferred, assigned or sold by the holders until 30 days after the completion of the initial Business Combination, (iii) may be exercised by the holders on a cashless basis and (iv) will be entitled to registration rights. If the Private Placement Warrants are held by holders other than the Sponsor or its permitted transferees, the Private Placement Warrants will be redeemable by the Company and exercisable by the holders on the same basis as the Public Warrants. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants): </div></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: 'times new roman'; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"> </td><td style="text-align:left;;vertical-align:top;;width:4%;">•</td><td style="font-family: 'times new roman';;vertical-align:top;;width:1%;"> </td><td style="text-align:left;;vertical-align:top;"><div style="font-family: 'times new roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">in whole and not in part; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: 'times new roman'; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"> </td><td style="text-align:left;;vertical-align:top;;width:4%;">•</td><td style="font-family: 'times new roman';;vertical-align:top;;width:1%;"> </td><td style="text-align:left;;vertical-align:top;"><div style="font-family: 'times new roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">at a price of $0.01 per warrant; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: 'times new roman'; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"> </td><td style="text-align:left;;vertical-align:top;;width:4%;">•</td><td style="font-family: 'times new roman';;vertical-align:top;;width:1%;"> </td><td style="text-align:left;;vertical-align:top;"><div style="font-family: 'times new roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">upon a minimum of 30 days’ prior written notice of redemption; </div></div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: 'times new roman'; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"> </td><td style="text-align:left;;vertical-align:top;;width:4%;">•</td><td style="vertical-align:top;;width:1%;"> </td><td style="text-align:left;;vertical-align:top;"><div style="font-family: 'times new roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, the last reported sale price of the Common stock equals or exceeds $18.00 per share (as adjusted for share splits, share dividends, rights issuances, subdivisions, reorganizations, recapitalizations and the like) for any 20 trading days within <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">a 30-trading day period</div> ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and</div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="font-size: 6pt; margin-top: 0pt; margin-bottom: 0pt;"><div style="font-size: 6pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" cellpadding="0" cellspacing="0" style="font-family: 'times new roman'; font-size: 10pt; border-collapse: collapse; border-spacing: 0px;;width:100%;"><tr style="page-break-inside: avoid;"><td style="width:4%;"> </td><td style="text-align:left;;vertical-align:top;;width:4%;">•</td><td style="vertical-align:top;;width:1%;"> </td><td style="text-align:left;;vertical-align:top;"><div style="font-family: 'times new roman'; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt; line-height: normal;">if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and for the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">entire 30-day trading</div> period referred to above and continuing each day thereafter until the date of redemption.</div></td></tr></table><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="clear: both; max-height: 0px;"></div><div style="clear: both; max-height: 0px; background: none;"></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company calls the Public Warrants for redemption as described above, management will have the option to require all holders that wish to exercise the Public Warrants to do so on a “cashless basis,” as described in the warrant agreement. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Additionally, in no event will the Company be required to net cash settle any Warrants. If the Company is unable to complete the initial Business Combination within the Combination Period and the Company liquidates the funds held in the Trust Account, holders of warrants will not receive any of such funds with respect to their warrants, nor will they receive any distribution from the Company’s assets held outside of the Trust Account with the respect to such warrants. Accordingly, the warrants may expire worthless. </div></div><div> </div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

1500000

0.20 2300000 0.35

2875000

288

24712

-2837

-8592

2875000

288

24712

-11429

13571

-98230

2875000

288

24712

-109659

375000

0.20

2875000

11.50

P5Y

9.50

0.60

2875000

0.0950 4025000 1.15 0.1800 1.80 0.0001

6771

100051

42927

-42927

309707 223146

180975

138048

0.0001

25000

375000

0.50 12.50 6800000 0.50

3400000

300000

600000 0.50

300000

600000

1000000

0.50 10000

11500000

1500000

10.00

115000000

7300000

4000000

115000000

<div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Basis of Presentation </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020. </div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</div> and the final prospectus filed by the Company with the SEC on July 21, 2020 and July 15, 2020, respectively.</div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Deferred Offering Costs Associated with the Initial Public Offering </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred offering costs consist of legal, accounting, underwriting fees and other costs through the balance sheet date that were directly related to the Initial Public Offering and that were charged to stockholders’ equity upon the completion of the Initial Public Offering. </div></div> <table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

10.00 5000001 780000

375000

300000 <div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 3 — Initial Public Offering </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">On July 15, 2020, the Company consummated the Initial Public Offering of 11,500,000 Units, including the issuance of 1,500,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $115.0 million, and incurring offering costs of approximately $7.3 million, inclusive of approximately $4.0 million in deferred underwriting commissions. Each Unit consists of one share of common stock and one redeemable warrant (each, a “Public Warrant”). Each Public Warrant entitles the holder to <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">purchase one-half (1/2)</div> of one share of common stock at a price of $11.50 per whole share, subject to adjustment (see Note 6).</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Of the 11,500,000 Units sold in the Initial Public Offering, an aggregate of 1,000,000 Units were purchased by Primerose Development Group Ltd. (“Primerose”). Primerose also entered into an agreement with the Company providing that it will hold at least 1,000,000 shares of the Company’s common stock following the Initial Business Combination. Primerose’s commitment to hold at least 1,000,000 shares of the Company’s common stock following the Initial Business Combination was satisfied by a purchase of Units in the Initial Public Offering. </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

11500000

1500000

10.00

115000000

11.50

1000000 50000 0.1000

250000

1000000

18.00

11500000

(a) a lead underwriter or (b) minimally as a co-manager, with at least 30% of the economics; or, in the case of a three-handed deal 20% of the economics DE 25000 PTK.U PTK PTK WS Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50 Units, each consisting of one share of Common Stock, and one Warrant to acquire one-half of one share of Common Stock Common Stock, par value $0.0001 per share CA

<div style="font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 1 — Description of Organization and Business Operations </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">PTK Acquisition Corp. (the “Company”) was incorporated in Delaware on August 19, 2019. The Company was incorporated for the purpose of effecting a merger, amalgamation, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses (the “Business Combination”). The Company is an emerging growth company and, as such, the Company is subject to all of the risks associated with emerging growth companies. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">As of June 30, 2020, the Company had not commenced any operations. All activity for the period from August 19, 2019 (inception) through June 30, 2020 relates to the Company’s formation and the initial public offering (the “Initial Public Offering”) described below. The Company will not generate any operating revenues until after the completion of its initial Business Combination, at the earliest. The Company <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">will generate non-operating income in</div> the form of interest income on investments held in trust from the proceeds derived from the Initial Public Offering and the sale of the Private Placement Warrants (as defined below). The Company has selected December 31 as its fiscal year end.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s sponsor is PTK Holdings LLC, a Delaware limited liability company (the “Sponsor”). The registration statement for the Initial Public Offering was declared effective on July 13, 2020. On July 15, 2020, the Company consummated the Initial Public Offering of 11,500,000 units (the “Units” and, with respect to the common stock included in the Units, the “Public Shares”), including the issuance of 1,500,000 Units as a result of the underwriters’ exercise of their over-allotment option in full, at $10.00 per Unit, generating gross proceeds of $115.0 million, and incurring offering costs of approximately $7.3 million, inclusive of approximately $4.0 million in deferred underwriting commissions (Note 5). </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Simultaneously with the closing of the Initial Public Offering, the Company consummated the private placement (“Private Placement”) of 6,800,000 warrants (each, a “Private Placement Warrant” and collectively, the “Private Placement Warrants”), at a price of $0.50 per Private Placement Warrant to the Sponsor, generating gross proceeds to the Company of $3.4 million (Note 4). </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">Upon the closing of the Initial Public Offering and the Private Placement, $115.0 million ($10.00 per Unit) of the net proceeds of the Initial Public Offering and certain of the proceeds of the Private Placement was placed in a trust account (“Trust Account”), located in the United States with Continental Stock Transfer & Trust Company acting as trustee, and invested only in U.S. “government securities” within the meaning of Section 2(a)(16) of the Investment Company Act having a maturity of 180 days or less or in money market funds meeting certain conditions <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">under Rule 2a-7 promulgated under</div> the Investment Company Act which invest only in direct U.S. government treasury obligations, until the distribution of the Trust Account as described below.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management has broad discretion with respect to the specific application of the net proceeds of the Initial Public Offering and the sale of the Private Placement Warrants, although substantially all of the net proceeds are intended to be applied generally toward consummating a Business Combination. There is no assurance that the Company will be able to complete a Business Combination successfully. The Company must complete an initial Business Combination having an aggregate fair market value of at least 80% of the value of the assets held in the Trust Account (as defined below) (excluding the amount of deferred underwriting discounts held in trust and taxes payable on the income earned on the Trust Account) at the time of signing the agreement to enter into the initial Business Combination. However, the Company will only complete a Business Combination if the post-transaction company owns or acquires 50% or more of the outstanding voting securities of the target or otherwise acquires a controlling interest in the target business sufficient for it not to be required to register as an investment company under the Investment Company Act 1940, as amended (the “Investment Company Act”). </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;">The Company will provide its holders (the “Public Stockholders”) of its common stock, par value $0.0001, sold in the Initial Public Offering (the “Public Shares”), with the opportunity to redeem all or a portion of their Public Shares upon the completion of a Business Combination either (i) in connection with a stockholder meeting called to approve the Business Combination or (ii) by means of a tender offer. The decision as to whether the Company will seek stockholder approval of a Business Combination or conduct a tender offer will be made by the Company, solely in its discretion. The Public Stockholders will be entitled to redeem their Public Shares for a pro rata portion of the amount then in the Trust Account (initially anticipated to be $10.00 per Public Share), calculated as of two business days prior to the consummation of a Business Combination, including interest (which interest shall be net of taxes <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">payable). The per-share amount to</div> be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon consummation of the Business Combination and a majority of the Company’s common stock voted at the applicable meeting are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and the Company’s officers and directors have agreed to vote any Insider Shares (as defined below in Note 4) and Public Shares held by them in favor of a Business Combination. In addition, the Sponsor and the Company’s officers and directors have agreed to waive their redemption rights with respect to any Public Shares held by them in connection with the completion of a Business Combination.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Notwithstanding the foregoing redemption rights, if the Company seeks stockholder approval of its initial Business Combination and the Company does not conduct redemptions in connection with its initial Business Combination pursuant to the tender offer rules, the Company’s Amended and Restated Certificate of Incorporation will provide that a Public Stockholder, together with any affiliate of such stockholder or any other person with whom such stockholder is acting in concert or as a “group” (as defined under Section 13 of the Securities Exchange Act of 1934, as amended (the “Exchange Act”)), will be restricted from redeeming its shares with respect to more than an aggregate of 20% of the shares sold in the Initial Public Offering, without the prior consent of the Company. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor and the Company’s officers and directors agreed not to propose any amendment to the Company’s Amended and Restated Certificate of Incorporation (1) to modify the substance or timing of the Company’s obligation to redeem 100% of its Public Shares if the Company does not complete a Business Combination within 18 months from the closing of the Initial Public Offering, or January 15, 2022 (the “Combination Period”) or (2) which adversely affects the rights of holders of the Public Shares, unless the Company provides the Public Stockholders with the opportunity to redeem their Public Shares upon approval of any such amendment. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">If the Company is unable to complete a Business Combination within the Combination Period, the Company will (i) cease all operations except for the purpose of winding up, (ii) as promptly as reasonably possible but not more than ten business days thereafter, redeem 100% of the outstanding Public Shares for a pro rata portion of the funds held in the Trust Account (net of interest that may be used by the Company to pay income taxes or other taxes) which redemption will completely extinguish the Public Stockholders’ rights as stockholders (including the right to receive further liquidation distributions, if any), subject to applicable law, and (iii) as promptly as reasonably possible following such redemption, subject to the approval of the Company’s remaining holders of common stock and the Company’s board of directors, dissolve and liquidate, subject (in the case of (ii) and (iii) above) to the Company’s obligations under Delaware law to provide for claims of creditors and the requirements of other applicable law. The Company will pay the costs of any liquidation following the redemptions from its remaining assets outside of the Trust Account. If such funds are insufficient, the Sponsor has agreed to pay the funds necessary to complete such liquidation (currently anticipated to be no more than approximately $50,000) and has agreed not to seek repayment for such expenses. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Sponsor and the Company’s officers and directors, agreed to waive their liquidation rights with respect to any Founder Shares they hold if the Company fails to complete a Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares held by them if the Company fails to complete a Business Combination within the Combination Period). The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the allotted time frame and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account, or less than such amount in certain circumstances. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including, but not limited to, all vendors, service providers (excluding its independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of the Public Stockholders. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Liquidity and Capital Resources </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">As of June 30, 2020, the Company had approximately $138,000 in its operating bank accounts, working capital deficit of approximately $780,000. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Prior to the completion of the Initial Public</div><div style="font-size: 10pt; font-family: 'times new roman', serif; letter-spacing: 0px; top: 0px;;display:inline;"> Offering <div style="letter-spacing: 0px; top: 0px;;display:inline;">on</div> July<div style="letter-spacing: 0px; top: 0px;;display:inline;"> 15,</div></div><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> 2020, the Company’s liquidity needs were satisfied through the receipt of $25,000 from the Sponsor in exchange for the issuance of the Founder Shares, and a $300,000 Note issued to the Sponsor, which was converted in to private warrants upon closing of the Initial Public Offering (Note 4). Subsequent to the consummation of the Initial Public Offering and Private Placement in July 2020, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). To date, there were no amounts outstanding under any Working Capital Loans. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Based on the foregoing, management believes that the Company will have sufficient working capital and borrowing capacity to meet its needs through the earlier of the consummation of a Business Combination or one year from this filing. Over this time period, the Company will be using these funds for paying existing accounts payable, identifying and evaluating prospective initial Business Combination candidates, performing due diligence on prospective target businesses, paying for travel expenditures, selecting the target business to merge with or acquire, and structuring, negotiating and consummating the Business Combination. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="letter-spacing: 0px; top: 0px;;display:inline;"><div style="letter-spacing: 0px; top: 0px;;display:inline;">On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">“COVID-19</div> outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. Management continues to evaluate the impact of the <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">COVID-19</div> pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty. </div></div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-weight:bold;display:inline;">Note 2 — Summary of Significant Accounting Policies </div></div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Basis of Presentation </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The accompanying unaudited condensed financial statements are presented in U.S. dollars in conformity with accounting principles generally accepted in the United States of America (“GAAP”) for financial information and pursuant to the rules and regulations of the SEC. Accordingly, they do not include all of the information and footnotes required by GAAP. In the opinion of management, the unaudited condensed financial statements reflect all adjustments, which include only normal recurring adjustments necessary for the fair statement of the balances and results for the periods presented. Operating results for the period for the three and six months ended June 30, 2020 are not necessarily indicative of the results that may be expected through December 31, 2020. </div></div><div style="font-size: 1px; margin-top: 12px; margin-bottom: 0px;"><div style="font-size: 1px; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 0pt; margin-bottom: 0pt;">The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">8-K</div> and the final prospectus filed by the Company with the SEC on July 21, 2020 and July 15, 2020, respectively.</div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Emerging Growth Company </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;">Section 102(b)(1) of the Jumpstart Our Business Startups Act of 2012 (the “JOBS Act”) exempts emerging growth companies from being required to comply with new or revised financial accounting standards until private companies (that is, those that have not had a Securities Act registration statement declared effective or do not have a class of securities registered under the Exchange Act) are required to comply with the new or revised financial accounting standards. The JOBS Act provides that an emerging growth company can elect to opt out of the extended transition period and comply with the requirements that <div style="white-space: nowrap; letter-spacing: 0px; top: 0px;;display:inline;">apply to non-emerging growth companies but</div> any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.</div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">This may make comparison of the Company’s financial statements with another public company that is neither an emerging growth company nor an emerging growth company that has opted out of using the extended transition period difficult or impossible because of the potential differences in accounting standards used. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Concentration of Credit Risk </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Financial instruments that potentially subject the Company to concentrations of credit risk consist of cash accounts in a financial institution, which, at times, may exceed the Federal Depository Insurance Coverage of $250,000. The Company has not experienced losses on these accounts and management believes the Company is not exposed to significant risks on such accounts. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Cash and Cash Equivalents </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of </div><div style="font-size: 10pt; font-family: 'times new roman', serif; letter-spacing: 0px; top: 0px;;display:inline;">June 30</div><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">, 2020. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Financial Instruments </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The fair value of the Company’s assets and liabilities, which qualify as financial instruments under the FASB ASC 820, “Fair Value Measurement” approximates the carrying amounts represented in the balance sheet, primarily due to their short-term nature. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Use of Estimates </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The preparation of financial statements in conformity with U.S. GAAP requires the Company’s management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the financial statements and the reported amounts of expenses during the reporting periods. Actual results could differ from those estimates. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Deferred Offering Costs Associated with the Initial Public Offering </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">Deferred offering costs consist of legal, accounting, underwriting fees and other costs through the balance sheet date that were directly related to the Initial Public Offering and that were charged to stockholders’ equity upon the completion of the Initial Public Offering. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Net Loss Per Share of Common Stock </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share of common stock is computed by dividing net loss by the weighted average number of common stock outstanding during the period excluding shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 375,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited. At June 30, 2020 and December 31, 2019, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;">Income Taxes </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The Company follows the asset and liability method of accounting for income taxes under FASB ASC Topic 740, “Income Taxes.” Deferred tax assets and liabilities are recognized for the estimated future tax consequences attributable to differences between the financial statements carrying amounts of existing assets and liabilities and their respective tax bases. Deferred tax assets and liabilities are measured using enacted tax rates expected to apply to taxable income in the years in which those temporary differences are expected to be recovered or settled. The effect on deferred tax assets and liabilities of a change in tax rates is recognized in income in the period that included the enactment date. Valuation allowances are established, when necessary, to reduce deferred tax assets to the amount expected to be realized. Deferred tax assets were deemed immaterial as of June 30, 2020. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">FASB ASC Topic 740 prescribes a recognition threshold and a measurement attribute for the financial statement recognition and measurement of tax positions taken or expected to be taken in a tax return. For those benefits to be recognized, a tax position must be more likely than not to be sustained upon examination by taxing authorities. There were no unrecognized tax benefits as of June 30, 2020. The Company recognizes accrued interest and penalties related to unrecognized tax benefits as income tax expense. No amounts were accrued for the payment of interest and penalties as of June 30, 2020. The Company is currently not aware of any issues under review that could result in significant payments, accruals or material deviation from its position. The Company is subject to income tax examinations by major taxing authorities since inception. </div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 12pt; margin-bottom: 0pt;"><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;">The provision for income taxes was deemed to be immaterial as of June 30, 2020. </div></div><div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-size: 10pt; font-family: 'times new roman', serif; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Standards </div></div><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"> </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-size: 10pt; font-family: 'times new roman', serif; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management does not believe that there are any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. </div><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

<div style="font-family: times new roman; font-size: 10pt; margin-top: 18pt; margin-bottom: 0pt;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"><div style="font-size: 10pt; font-family: 'times new roman', serif; letter-spacing: 0px; top: 0px;;display:inline;">Recent Accounting Standards </div></div><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"><div style="font-style:italic;display:inline;;font-style:italic;display:inline;"> </div></div></div><div style="text-indent: 4%; font-family: times new roman; font-size: 10pt; margin-top: 6pt; margin-bottom: 0pt;"><div style="font-size: 10pt; font-family: 'times new roman', serif; letter-spacing: 0px; top: 0px;;display:inline;">The Company’s management does not believe that there are any recently issued, but not yet effective, accounting standards, if currently adopted, would have a material effect on the Company’s unaudited condensed financial statements. </div><div style="font-family: 'times new roman'; font-size: 10pt; letter-spacing: 0px; top: 0px;;display:inline;"> </div></div><table border="0" style="width:100%; table-layout:fixed;" cellspacing="0" cellpadding="0"><tr><td></td></tr></table>

iso4217:USD xbrli:shares xbrli:pure iso4217:USD xbrli:shares This number includes up to 375,000 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited. This number excludes an aggregate of up to 375,000 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited.

EX-101.SCH 7 ptk-20200630.xsd XBRL TAXONOMY EXTENSION SCHEMA 1001 - Document - Cover Page link:presentationLink link:definitionLink link:calculationLink 1002 - Statement - Condensed Balance Sheets link:presentationLink link:definitionLink link:calculationLink 1003 - Statement - Condensed Balance Sheets (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1004 - Statement - Condensed Statements of Operations link:presentationLink link:definitionLink link:calculationLink 1005 - Statement - Condensed Statements of Operations (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1006 - Statement - Condensed Statements of Changes in Shareholder's Equity link:presentationLink link:definitionLink link:calculationLink 1007 - Statement - Condensed Statements of Changes in Shareholder's Equity (Parenthetical) link:presentationLink link:definitionLink link:calculationLink 1008 - Statement - Condensed Statement of Cash Flows link:presentationLink link:definitionLink link:calculationLink 1009 - Disclosure - Description of Organization and Business Operations link:presentationLink link:definitionLink link:calculationLink 1010 - Disclosure - Summary of Significant Accounting Policies link:presentationLink link:definitionLink link:calculationLink 1011 - Disclosure - Initial Public Offering link:presentationLink link:definitionLink link:calculationLink 1012 - Disclosure - Related Party Transactions link:presentationLink link:definitionLink link:calculationLink 1013 - Disclosure - Commitments & Contingencies link:presentationLink link:definitionLink link:calculationLink 1014 - Disclosure - Stockholder's Equity link:presentationLink link:definitionLink link:calculationLink 1015 - Disclosure - Subsequent Events link:presentationLink link:definitionLink link:calculationLink 1016 - Disclosure - Summary of Significant Accounting Policies (Policies) link:presentationLink link:definitionLink link:calculationLink 1017 - Disclosure - Description of Organization and Business Operations - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1018 - Disclosure - Summary of Significant Accounting Policies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1019 - Disclosure - Initial Public Offering - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1020 - Disclosure - Related Party Transactions - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1021 - Disclosure - Commitments & Contingencies - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink 1022 - Disclosure - Stockholder's Equity - Additional Information (Detail) link:presentationLink link:definitionLink link:calculationLink EX-101.CAL 8 ptk-20200630_cal.xml XBRL TAXONOMY EXTENSION CALCULATION LINKBASE EX-101.DEF 9 ptk-20200630_def.xml XBRL TAXONOMY EXTENSION DEFINITION LINKBASE EX-101.LAB 10 ptk-20200630_lab.xml XBRL TAXONOMY EXTENSION LABEL LINKBASE Cover [Abstract] Document Information [Table] Document Information [Table] Class of Stock [Axis] Class of Stock [Axis] Class of Stock [Domain] Class of Stock [Domain] Document Information [Line Items] Document Information [Line Items] Document Type Document Type Amendment Flag Amendment Flag Document Fiscal Year Focus Document Fiscal Year Focus Document Fiscal Period Focus Document Fiscal Period Focus Document Period End Date Document Period End Date Current Fiscal Year End Date Current Fiscal Year End Date Document Transition Report Document Transition Report Document Quarterly Report Document Quarterly Report Entity Registrant Name Entity Registrant Name Entity Central Index Key Entity Central Index Key Entity Filer Category Entity Filer Category Entity Current Reporting Status Entity Current Reporting Status Entity Interactive Data Current Entity Interactive Data Current Entity Common Stock, Shares Outstanding Entity Common Stock, Shares Outstanding Title of 12(b) Security Title of 12(b) Security Trading Symbol Trading Symbol Security Exchange Name Security Exchange Name Entity Small Business Entity Small Business Entity Emerging Growth Company Entity Emerging Growth Company Entity Ex Transition Period Entity Ex Transition Period Entity Shell Company Entity Shell Company Entity Incorporation, State or Country Code Entity Incorporation, State or Country Code Entity Address, State or Province Entity Address, State or Province Equity Components [Axis] Equity Components [Axis] Equity Component [Domain] Equity Component [Domain] Capital Units [Member] Capital Units [Member] Common Stock [Member] Common Stock [Member] Common Stock [Member] Warrant [Member] Warrant [Member] Statement of Financial Position [Abstract] Statement [Table] Statement [Line Items] Assets [Abstract] Assets: Assets, Current [Abstract] Current assets: Cash Cash Assets, Current Total current assets Deferred Costs, Noncurrent Deferred offering costs associated with the initial public offering Assets Total assets Liabilities and Equity [Abstract] Liabilities and Stockholder's Equity (Deficit): Liabilities, Current [Abstract] Current liabilities: Accounts Payable, Current Accounts payable Accrued Liabilities, Current Accrued expenses Accrual for Taxes Other than Income Taxes, Current Franchise tax payable Due to Related Parties, Current Note payable - related party Liabilities, Current Total current liabilities Commitments and Contingencies Commitments and Contingencies Stockholders' Equity Attributable to Parent [Abstract] Stockholder's Equity: Common Stock, Value, Issued Common stock, $0.0001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding Additional Paid in Capital Additional paid-in capital Retained Earnings (Accumulated Deficit) Accumulated deficit Stockholders' Equity Attributable to Parent Total stockholder's equity (deficit) Beginning balance Ending balance Liabilities and Equity Total liabilities and stockholder's equity (deficit) Common Stock, Par or Stated Value Per Share Common Stock, Par Value Common stock par value Common Stock, Shares Authorized Common Stock, Shares Authorized Common stock shares authorized Common Stock, Shares, Issued Common Stock, Shares, Issued Common Stock, Shares, Outstanding Common Stock, Shares, Outstanding Beginning balance (in shares) Ending balance (in shares) Common stock outstanding Common Stock Shares Outstanding Subject To Forfeiture Common Stock, Shares Outstanding, Subject To Forfeiture Common Stock, Shares Outstanding, Subject To Forfeiture Common Stock, Shares Outstanding, Subject To Forfeiture. Income Statement [Abstract] General and Administrative Expense General and administrative expenses Franchise tax expense Franchise tax expense Franchise tax expense. Net Income (Loss) Attributable to Parent Net loss Net loss Net loss Weighted Average Number of Shares Outstanding, Basic and Diluted Weighted average shares outstanding, basic and diluted Earnings Per Share, Basic and Diluted Basic and diluted net loss per share Statement of Stockholders' Equity [Abstract] Additional Paid-in Capital [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Accumulated Deficit [Member] Statement of Cash Flows [Abstract] Net Cash Provided by (Used in) Operating Activities [Abstract] Cash Flows from Operating Activities: Increase (Decrease) in Operating Capital [Abstract] Changes in operating assets and liabilities: Increase (Decrease) in Accounts Payable Accounts payable Increase (Decrease) in Property and Other Taxes Payable Franchise tax payable Net Cash Provided by (Used in) Operating Activities Net cash used in operating activities Net Cash Provided by (Used in) Financing Activities [Abstract] Cash Flows from Financing Activities: Payment of Financing and Stock Issuance Costs Deferred offering costs paid Net Cash Provided by (Used in) Financing Activities Net cash used in financing activities Cash Flow, Noncash Investing and Financing Activities Disclosure [Abstract] Supplemental disclosure of noncash activities: Deferred offering costs included in accounts payable Deferred offering costs included in accounts payable. Deferred offering costs included in accrued expenses Deferred offering costs included in accrued expenses. Cash and Cash Equivalents, Period Increase (Decrease) Net change in cash Cash and Cash Equivalents, at Carrying Value Cash - beginning of the period Cash - end of the period Operating bank accounts Organization, Consolidation and Presentation of Financial Statements [Abstract] Organization, Consolidation and Presentation of Financial Statements Disclosure [Text Block] Description of Organization and Business Operations Accounting Policies [Abstract] Business Description and Accounting Policies [Text Block] Summary of Significant Accounting Policies Equity [Abstract] Equity [Abstract] Initial Public Offering Disclosure [Text Block] Initial Public Offering Initial Public Offering Disclosure Related Party Transactions [Abstract] Related Party Transactions Disclosure [Text Block] Related Party Transactions Commitments and Contingencies Disclosure [Abstract] Commitments and Contingencies Disclosure [Text Block] Commitments & Contingencies Stockholders' Equity Note Disclosure [Text Block] Stockholder's Equity Subsequent Events [Abstract] Subsequent Events [Abstract] Subsequent Events [Text Block] Subsequent Events Basis of Presentation and Significant Accounting Policies [Text Block] Basis of Presentation Emerging Growth Company [Policy Text Block] Emerging Growth Company Emerging growth company policies text block. Concentration Risk, Credit Risk, Policy [Policy Text Block] Concentration of Credit Risk Cash and Cash Equivalents, Policy [Policy Text Block] Cash and Cash Equivalents Fair Value of Financial Instruments, Policy [Policy Text Block] Financial Instruments Use of Estimates, Policy [Policy Text Block] Use of Estimates Deferred Offering Costs Associated with the Initial Public Offering [Policy Text Block] Deferred Offering Costs Associated with the Initial Public Offering Deferred offering costs associated with the initial public offering policy text block. Earnings Per Share, Policy [Policy Text Block] Net Loss Per Share of Common Stock Income Tax, Policy [Policy Text Block] Income Taxes New Accounting Pronouncements, Policy [Policy Text Block] Recent Accounting Standards Organisation Consolidation and Presentation of Financial Statements [Table] Organisation consolidation and presentation of financial statements [Table]. Common Class A [Member] Common Class A [Member] Sale of Stock [Axis] Sale of Stock [Domain] IPO [Member] IPO [Member] Over-Allotment Option [Member] Over-Allotment Option [Member] Class of Warrant or Right [Axis] Class of Warrant or Right [Domain] Private Placement Warrants [Member] Private Placement Warrants [Member] Statistical Measurement [Axis] Statistical Measurement [Domain] Maximum [Member] Maximum [Member] Subsequent Event Type [Axis] Subsequent Event Type [Domain] Organisation Consolidation and Presentation of Financial Statements [Line Items] Organisation consolidation and presentation of financial statements [Line Items]. Stock Issued During Period, Shares, New Issues Initial Public Offering, units issued Additional units purchased which includes the full exercise by the underwriter of the over-allotment option Stock issued during period Shares Issued, Price Per Share Initial Public Offering, price per unit Initial Public Offering, price per unit Proceeds from Issuance Initial Public Offering Proceeds from issuance initial public offering Initial Public Offering Costs Initial Public Offering, offering costs Initial Public Offering Costs. Deferred Offering Costs Initial Public Offering, deferred underwriting commissions Initial Public Offering, deferred underwriting commissions Proceeds from Issuance of Warrants Proceeds from issue of warrants Gross proceeds from warrants Assets Held-in-trust Assets held in trust Redemption Price Per Share Redemption price per share Redemption Price Per Share. Minimum Tangible Assets For Business Combination Minimum tangible assets for business combination Minimum Tangible Assets For Business Combination Working Capital working capital deficit working capital deficit. Proceeds From Sale Of Founder Shares Proceeds from sale of founder shares Proceeds from sale of founder shares. Working Capital Loans Converted To Warrants Working capital loans converted to warrants Working Capital Loans Converted To Warrants Number Of Warrants Issued Number of warrants issued Number of warrants issued. Issue Price Per Warrant Issue price per warrant Issue price per warrant. Liquidation Cost Agreed by Sponsor to Pay Liquidation Cost agreed by sponsor to pay Liquidation cost agreed by sponsor to pay. Per Share Value of the Residual Assets Remaining Available for Distribution Per share value of the residual assets remaining available for distribution Per share value of the residual assets remaining available for distribution. Weighted Average Number of Shares, Common Stock Subject to Repurchase or Cancellation Weighted average shares of common stock that are subject to forfeiture Cash, FDIC Insured Amount Cash insured Subsidiary or Equity Method Investee, Sale of Stock by Subsidiary or Equity Investee [Table] Legal Entity [Axis] Entity [Domain] Primerose [Member] Primerose Class of Warrant or Right [Line Items] Class of Warrant or Right, Exercise Price of Warrants or Rights Common stock warrants exercise price per share Class of warrant or right exercise price Number of shares promised to hold Number of shares promised to hold Sale of Stock, Number of Shares Issued in Transaction Units acquired by Primerose Development Group Ltd. Schedule of Related Party Transactions, by Related Party [Table] Related Party [Axis] Related Party [Domain] Sponsor [Member] Debt Instrument [Axis] Debt Instrument, Name [Domain] Note [Member] Working Capital Loan [Member] Scenario [Axis] Scenario [Domain] Forecast [Member] Subsequent Event [Member] Related Party Transaction [Line Items] Proceeds from Issuance of Common Stock Proceeds from common stock Shares Issued, Shares, Share-based Payment Arrangement, Forfeited Number of shares forfeited Shares subject to forfeiture Percent Of Shares Not Transferable Percent of shares not transferable Percent of shares not transferable. Stock Price Threshold Limit Stock price threshold limit Stock price threshold limit. Debt Instrument, Face Amount Debt instrument face amount Payment For Overhead And Administration Support Payment for overhead and administration support. Subsidiary, Sale of Stock [Line Items] Underwriting Discount Per Share Underwriting discount per share Underwriting Discount Per Share Underwriting Discount Underwriting discount Underwriting Discount Deferred Underwriting Commissions Per Share Deferred underwriting commissions per share Deferred Underwriting Commissions Per Share Deferred Underwriting Commissions Deferred Underwriting Commissions Underwriting Description Underwriting Description Percent Of Number Of Insider Shares To Outstanding Shares Percent of number of insider shares to outstanding shares Percent of number of insider shares to outstanding shares. Class Of Warrant Or Right Expire Period Class of warrant or right expire period Class of warrant or right expire period. Sale of Stock, Price Per Share Sale of Stock, Price Per Share Percent Of Gross Proceeds To Total Equity Proceeds Percent of gross proceeds to total equity proceeds Percent of gross proceeds to total equity proceeds. Volume Weighted Average Trading Price Volume weighted average trading price Volume weighted average trading price. Percent Of Exercise Price Of Warrant To Market Price Percent of exercise price of warrant to market price Percent of exercise price of warrant to market price. Redemption Trigger Price Of Warrant Redemption trigger price of warrant Redemption trigger price of warrant. Percent Of Redemption Price Of Warrant To Market Value Percent of redemption price of warrant to market value Percent of redemption price of warrant to market value. Redemption Price Of Warrant Redemption price of warrant Redemption price of warrant. EX-101.PRE 11 ptk-20200630_pre.xml XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE XML 12 R1.htm IDEA: XBRL DOCUMENT

Cover Page - shares	6 Months Ended
Cover Page - shares	Jun. 30, 2020	Aug. 26, 2020
Document Information [Line Items]
Document Type	10-Q
Amendment Flag	false
Document Quarterly Report	true
Document Transition Report	false
Document Fiscal Year Focus	2020
Document Fiscal Period Focus	Q2
Document Period End Date	Jun. 30, 2020
Current Fiscal Year End Date	--12-31
Entity Registrant Name	PTK Acquisition Corp.
Entity Central Index Key	0001797099
Entity Incorporation, State or Country Code	DE
Entity Address, State or Province	CA
Entity Current Reporting Status	No
Entity Interactive Data Current	Yes
Entity Filer Category	Non-accelerated Filer
Entity Small Business	true
Entity Emerging Growth Company	true
Entity Ex Transition Period	false
Entity Shell Company	true
Entity Common Stock, Shares Outstanding		14,375,000
Capital Units [Member]
Document Information [Line Items]
Title of 12(b) Security	Units, each consisting of one share of Common Stock, and one Warrant to acquire one-half of one share of Common Stock
Trading Symbol	PTK.U
Security Exchange Name	NYSE
Common Stock [Member]
Document Information [Line Items]
Title of 12(b) Security	Common Stock, par value $0.0001 per share
Trading Symbol	PTK
Security Exchange Name	NYSE
Warrant [Member]
Document Information [Line Items]
Title of 12(b) Security	Warrants, each whole warrant exercisable for one share of Common Stock at an exercise price of $11.50
Trading Symbol	PTK WS
Security Exchange Name	NYSE

XML 13 R2.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets - USD ($)

Jun. 30, 2020

Dec. 31, 2019

Current assets:

Cash

$ 138,048

$ 180,975

Total current assets

138,048

180,975

Deferred offering costs associated with the initial public offering

797,481

246,879

Total assets

935,529

427,854

Current liabilities:

Accounts payable

394,789

103,489

Accrued expenses

223,146

Franchise tax payable

102,253

2,202

Note payable - related party

300,000

Total current liabilities

1,020,188

405,691

Commitments and Contingencies

Stockholder's Equity:

Common stock, $0.0001 par value; 100,000,000 shares authorized; 2,875,000 shares issued and outstanding

^[1]

288

Additional paid-in capital

24,712

Accumulated deficit

(109,659)

(2,837)

Total stockholder's equity (deficit)

(84,659)

22,163

Total liabilities and stockholder's equity (deficit)

$ 935,529

$ 427,854

[1]	This number includes up to 375,000 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited.

XML 14 R3.htm IDEA: XBRL DOCUMENT

Condensed Balance Sheets (Parenthetical)	Jun. 30, 2020 $ / shares shares
Statement of Financial Position [Abstract]
Common Stock, Par Value \| $ / shares	$ 0.0001
Common Stock, Shares Authorized	100,000,000
Common Stock, Shares, Issued	2,875,000
Common Stock, Shares, Outstanding	2,875,000
Common Stock, Shares Outstanding, Subject To Forfeiture	375,000

XML 15 R4.htm IDEA: XBRL DOCUMENT

Condensed Statements of Operations - USD ($)

3 Months Ended

6 Months Ended

Jun. 30, 2020

General and administrative expenses

$ 202

$ 6,771

Franchise tax expense

98,028

100,051

Net loss

$ (98,230)

$ (106,822)

Weighted average shares outstanding, basic and diluted

^[1]

2,500,000

Basic and diluted net loss per share

$ (0.04)

[1]	This number excludes an aggregate of up to 375,000 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited.

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

Reference 1: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1A
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669619-108580

Reference 2: http://www.xbrl.org/2003/role/exampleRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 31
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8924-108599

Reference 3: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 942
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.9-04(22))
-URI http://asc.fasb.org/extlink&oid=120399700&loc=SL114874048-224260

Reference 5: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 11
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22694-107794

Reference 6: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 7: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 205
-SubTopic 20
-Section 50
-Paragraph 7
-URI http://asc.fasb.org/extlink&oid=109222650&loc=SL51721683-107760

Reference 8: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 4
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22595-107794

Reference 9: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section 45
-Paragraph 1B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121641772&loc=SL7669625-108580

Reference 10: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 22
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8736-108599

Reference 11: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 944
-SubTopic 220
-Section S99
-Paragraph 1
-Subparagraph (SX 210.7-04(18))
-URI http://asc.fasb.org/extlink&oid=120400993&loc=SL114874131-224263

Reference 12: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 220
-SubTopic 10
-Section S99
-Paragraph 2
-Subparagraph (SX 210.5-03(20))
-URI http://asc.fasb.org/extlink&oid=120395209&loc=SL114868664-224227

Reference 13: http://fasb.org/us-gaap/role/ref/legacyRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 230
-SubTopic 10
-Section 45
-Paragraph 28
-URI http://asc.fasb.org/extlink&oid=121586364&loc=d3e3602-108585

Reference 14: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 1
-Subparagraph (b)(2)
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22499-107794

Reference 15: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 9
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22663-107794

Reference 16: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 825
-SubTopic 10
-Section 50
-Paragraph 28
-Subparagraph (f)
-URI http://asc.fasb.org/extlink&oid=75031198&loc=d3e14064-108612

Reference 17: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 30
-Subparagraph (b)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8906-108599

Reference 18: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 3
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22583-107794

Reference 19: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 235
-SubTopic 10
-Section S99
-Paragraph 1
-Subparagraph (SX 210.4-08(g)(1)(ii))
-URI http://asc.fasb.org/extlink&oid=120395691&loc=d3e23780-122690

Reference 20: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 260
-SubTopic 10
-Section 45
-Paragraph 60B
-Subparagraph (a)
-URI http://asc.fasb.org/extlink&oid=121326447&loc=SL5780133-109256

Reference 21: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 323
-SubTopic 10
-Section 50
-Paragraph 3
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=114001798&loc=d3e33918-111571

Reference 22: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 280
-SubTopic 10
-Section 50
-Paragraph 32
-Subparagraph (c)
-URI http://asc.fasb.org/extlink&oid=120311839&loc=d3e8933-108599

Reference 23: http://www.xbrl.org/2003/role/disclosureRef
-Publisher FASB
-Name Accounting Standards Codification
-Topic 250
-SubTopic 10
-Section 50
-Paragraph 8
-URI http://asc.fasb.org/extlink&oid=109234566&loc=d3e22658-107794

+ Details

XML 16 R5.htm IDEA: XBRL DOCUMENT

Condensed Statements of Operations (Parenthetical)	Jun. 30, 2020 shares
Income Statement [Abstract]
Common Stock, Shares Outstanding, Subject To Forfeiture	375,000

XML 17 R6.htm IDEA: XBRL DOCUMENT

Condensed Statements of Changes in Shareholder's Equity - USD ($)

Total

Common Stock [Member]

Additional Paid-in Capital [Member]

Accumulated Deficit [Member]

Beginning balance at Dec. 31, 2019

$ 22,163

$ 288

$ 24,712

$ (2,837)

Beginning balance (in shares) at Dec. 31, 2019

2,875,000

^[1]

Net loss

$ (8,592)

(8,592)

Ending balance at Mar. 31, 2020

13,571

$ 288

24,712

(11,429)

Ending balance (in shares) at Mar. 31, 2020

^[1]

2,875,000

Beginning balance at Dec. 31, 2019

$ 22,163

$ 288

24,712

(2,837)

Beginning balance (in shares) at Dec. 31, 2019

2,875,000

^[1]

Net loss

$ (106,822)

Ending balance at Jun. 30, 2020

$ (84,659)

$ 288

24,712

(109,659)

Ending balance (in shares) at Jun. 30, 2020

2,875,000

^[1]

Beginning balance at Mar. 31, 2020

$ 13,571

$ 288

24,712

(11,429)

Beginning balance (in shares) at Mar. 31, 2020

^[1]

2,875,000

Net loss

(98,230)

Ending balance at Jun. 30, 2020

$ (84,659)

$ 288

$ 24,712

$ (109,659)

Ending balance (in shares) at Jun. 30, 2020

2,875,000

^[1]

[1]	This number includes up to 375,000 shares of common stock subject to forfeiture if the over-allotment option is not exercised in full or in part by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited.

- Definition

The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.

+ References

+ Details

- Definition

Total of all stockholders' equity (deficit) items, net of receivables from officers, directors, owners, and affiliates of the entity which are attributable to the parent. The amount of the economic entity's stockholders' equity attributable to the parent excludes the amount of stockholders' equity which is allocable to that ownership interest in subsidiary equity which is not attributable to the parent (noncontrolling interest, minority interest). This excludes temporary equity and is sometimes called permanent equity.

+ References + Details

XML 18 R7.htm IDEA: XBRL DOCUMENT

Condensed Statements of Changes in Shareholder's Equity (Parenthetical)	Jun. 30, 2020 shares
Statement of Stockholders' Equity [Abstract]
Common Stock, Shares Outstanding, Subject To Forfeiture	375,000

XML 19 R8.htm IDEA: XBRL DOCUMENT

Condensed Statement of Cash Flows	6 Months Ended
Condensed Statement of Cash Flows	Jun. 30, 2020 USD ($)
Cash Flows from Operating Activities:
Net loss	$ (106,822)
Changes in operating assets and liabilities:
Accounts payable	6,771
Franchise tax payable	100,051
Net cash used in operating activities	0
Cash Flows from Financing Activities:
Deferred offering costs paid	(42,927)
Net cash used in financing activities	(42,927)
Net change in cash	(42,927)
Cash - beginning of the period	180,975
Cash - end of the period	138,048
Supplemental disclosure of noncash activities:
Deferred offering costs included in accounts payable	309,707
Deferred offering costs included in accrued expenses	$ 223,146

XML 20 R9.htm IDEA: XBRL DOCUMENT

Description of Organization and Business Operations

6 Months Ended

Jun. 30, 2020

Organization, Consolidation and Presentation of Financial Statements [Abstract]

Description of Organization and Business Operations

Note 1 — Description of Organization and Business Operations

will generate non-operating income in

the form of interest income on investments held in trust from the proceeds derived from the Initial Public Offering and the sale of the Private Placement Warrants (as defined below). The Company has selected December 31 as its fiscal year end.

under Rule 2a-7 promulgated under

the Investment Company Act which invest only in direct U.S. government treasury obligations, until the distribution of the Trust Account as described below.

payable). The per-share amount to

be distributed to Public Stockholders who redeem their Public Shares will not be reduced by the deferred underwriting commissions the Company will pay to the underwriters (as discussed in Note 5). In such case, the Company will proceed with a Business Combination if the Company has net tangible assets of at least $5,000,001 either prior to or upon consummation of the Business Combination and a majority of the Company’s common stock voted at the applicable meeting are voted in favor of the Business Combination. If a stockholder vote is not required by applicable law or stock exchange listing requirements and the Company does not decide to hold a stockholder vote for business or other reasons, the Company will, pursuant to its Amended and Restated Certificate of Incorporation, conduct the redemptions pursuant to the tender offer rules of the U.S. Securities and Exchange Commission (“SEC”) and file tender offer documents with the SEC prior to completing a Business Combination. If, however, stockholder approval of the transactions is required by applicable law or stock exchange listing requirements, or the Company decides to obtain stockholder approval for business or legal reasons, the Company will offer to redeem shares in conjunction with a proxy solicitation pursuant to the proxy rules and not pursuant to the tender offer rules. Additionally, each Public Stockholder may elect to redeem their Public Shares irrespective of whether they vote for or against the proposed transaction or vote at all. If the Company seeks stockholder approval in connection with a Business Combination, the Sponsor and the Company’s officers and directors have agreed to vote any Insider Shares (as defined below in Note 4) and Public Shares held by them in favor of a Business Combination. In addition, the Sponsor and the Company’s officers and directors have agreed to waive their redemption rights with respect to any Public Shares held by them in connection with the completion of a Business Combination.

The Sponsor and the Company’s officers and directors, agreed to waive their liquidation rights with respect to any Founder Shares they hold if the Company fails to complete a Business Combination within the Combination Period (although they will be entitled to liquidating distributions from the Trust Account with respect to any Public Shares held by them if the Company fails to complete a Business Combination within the Combination Period). The underwriters agreed to waive their rights to the deferred underwriting commission (see Note 5) held in the Trust Account in the event the Company does not complete a Business Combination within the allotted time frame and, in such event, such amounts will be included with the funds held in the Trust Account that will be available to fund the redemption of the Public Shares. In the event of such distribution, it is possible that the per share value of the residual assets remaining available for distribution (including Trust Account assets) will be only $10.00 per share initially held in the Trust Account, or less than such amount in certain circumstances. In order to protect the amounts held in the Trust Account, the Sponsor has agreed that it will be liable to the Company if and to the extent any claims by a third party (excluding the Company’s independent registered public accounting firm) for services rendered or products sold to the Company, or a prospective target business with which the Company has discussed entering into a transaction agreement, reduce the amount of funds in the Trust Account. This liability will not apply to any claims by a third party who executed a waiver of any and all rights to seek access to the Trust Account nor will it apply to any claims under the Company’s indemnity of the underwriters of the Initial Public Offering against certain liabilities, including liabilities under the Securities Act of 1933, as amended (the “Securities Act”). Moreover, in the event that an executed waiver is deemed to be unenforceable against a third party, the Sponsor will not be responsible to the extent of any liability for such third-party claims. The Company will seek to have all third parties, including, but not limited to, all vendors, service providers (excluding its independent registered public accounting firm), prospective target businesses and other entities with which the Company does business execute agreements with the Company waiving any right, title, interest or claim of any kind in or to any monies held in the Trust Account for the benefit of the Public Stockholders.

Liquidity and Capital Resources

As of June 30, 2020, the Company had approximately $138,000 in its operating bank accounts, working capital deficit of approximately $780,000.

Prior to the completion of the Initial Public

Offering

July

15,

2020, the Company’s liquidity needs were satisfied through the receipt of $25,000 from the Sponsor in exchange for the issuance of the Founder Shares, and a $300,000 Note issued to the Sponsor, which was converted in to private warrants upon closing of the Initial Public Offering (Note 4). Subsequent to the consummation of the Initial Public Offering and Private Placement in July 2020, the Company’s liquidity needs have been satisfied with the proceeds from the consummation of the Private Placement not held in the Trust Account. In addition, in order to finance transaction costs in connection with a Business Combination, the Sponsor may, but are not obligated to, provide the Company Working Capital Loans (see Note 4). To date, there were no amounts outstanding under any Working Capital Loans.

On January 30, 2020, the World Health Organization (“WHO”) announced a global health emergency because of a new strain of coronavirus (the

“COVID-19

outbreak”). In March 2020, the WHO classified the COVID-19 outbreak as a pandemic, based on the rapid increase in exposure globally. The full impact of the COVID-19 outbreak continues to evolve. Management continues to evaluate the impact of the

COVID-19

pandemic and has concluded that the specific impact is not readily determinable as of the date of the balance sheet. The unaudited condensed financial statements do not include any adjustments that might result from the outcome of this uncertainty.

XML 21 R10.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Summary of Significant Accounting Policies

Note 2 — Summary of Significant Accounting Policies

Basis of Presentation

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form

8-K

and the final prospectus filed by the Company with the SEC on July 21, 2020 and July 15, 2020, respectively.

Emerging Growth Company

apply to non-emerging growth companies but

any such an election to opt out is irrevocable. The Company has elected not to opt out of such extended transition period, which means that when a standard is issued or revised and it has different application dates for public or private companies, the Company, as an emerging growth company, can adopt the new or revised standard at the time private companies adopt the new or revised standard.

Concentration of Credit Risk

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of

June 30

, 2020.

Financial Instruments

Use of Estimates

Deferred Offering Costs Associated with the Initial Public Offering

Net Loss Per Share of Common Stock

The Company complies with accounting and disclosure requirements of FASB ASC Topic 260, “Earnings Per Share.” Net loss per share of common stock is computed by dividing net loss by the weighted average number of common stock outstanding during the period excluding shares subject to forfeiture. Weighted average shares were reduced for the effect of an aggregate of 375,000 shares of common stock that are subject to forfeiture if the over-allotment option is not exercised by the underwriters. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, none of these shares were forfeited. At June 30, 2020 and December 31, 2019, the Company did not have any dilutive securities and other contracts that could, potentially, be exercised or converted into common stock and then share in the earnings of the Company. As a result, diluted loss per share is the same as basic loss per share for the periods presented.

Income Taxes

The provision for income taxes was deemed to be immaterial as of June 30, 2020.

Recent Accounting Standards

XML 22 R11.htm IDEA: XBRL DOCUMENT

Initial Public Offering

6 Months Ended

Jun. 30, 2020

Equity [Abstract]

Initial Public Offering

Note 3 — Initial Public Offering

purchase one-half (1/2)

of one share of common stock at a price of $11.50 per whole share, subject to adjustment (see Note 6).

XML 23 R12.htm IDEA: XBRL DOCUMENT

Related Party Transactions

6 Months Ended

Jun. 30, 2020

Related Party Transactions

Note 4 — Related Party Transactions

Insider Shares

within any 30-trading day period

commencing after the consummation of the initial Business Combination and the remaining 50% of the Insider Shares will not be transferred, assigned, sold or released from escrow until six months after the date of the consummation of the initial Business Combination, or earlier, in either case, if, subsequent to the initial Business Combination, the Company completes a liquidation, merger, stock exchange or other similar transaction which results in all of the Company’s stockholders having the right to exchange their shares of common stock for cash, securities or other property. The limited exceptions referred to above include (1) transfers among the insiders, to the Company’s officers, directors, advisors and employees, (2) transfers to an insider’s affiliates or its members upon its liquidation, (3) transfers to relatives and trusts for estate planning purposes, (4) transfers by virtue of the laws of descent and distribution upon death, (5) transfers pursuant to a qualified domestic relations order, (6) private sales made at prices no greater than the price at which the securities were originally purchased or (7) transfers to the Company for cancellation in connection with the consummation of an initial Business Combination, in each case (except for clause 7) where the transferee agrees to the terms of the escrow agreement and forfeiture, as the case may be, as well as the other applicable restrictions and agreements of the holders of the Insider Shares.

Private Placement Warrants

Related Party Loans

non-interest

bearing, and on July 9, 2020 the Company amended such loan to provide that such loan: (A) was convertible into 600,000 private warrants issuable to the Sponsor at a purchase price of $0.50 per

warrant upon the consummation of the Initial Public Offering; or (B) due in cash to the Sponsor on the date the Company determines not to proceed with the Initial Public Offering. The Company fully borrowed the

Note amount of $

300,000

f June

2020

. The Note was converted into

600,000

private warrants upon the consummation of the Initial Public Offering on July

2020

Administrative Support Agreement

XML 24 R13.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies

6 Months Ended

Jun. 30, 2020

Commitments and Contingencies Disclosure [Abstract]

Commitments & Contingencies

Note 5 — Commitments & Contingencies

Registration Rights

Underwriting Agreement

The Company granted the

underwriters a 45-day option from the

final prospectus relating to the Initial Public Offering to purchase up to 1,500,000 additional Units to cover over-allotments, if any, at the Initial Public Offering price less the underwriting discounts and commissions. The underwriters fully exercised their over-allotment option on July 15, 2020.

Right of First Refusal

a co-manager, with

at least 30% of the economics; or, in the case of a three-handed deal 20% of the economics, for any and all future public and private equity and debt offerings. In accordance with FINRA Rule 5110(f)(2)(E)(i), such right of first refusal shall not have a duration of more than three years from the effective date of the registration statement related to the Initial Public Offering.

XML 25 R14.htm IDEA: XBRL DOCUMENT

Stockholder's Equity

6 Months Ended

Jun. 30, 2020

Equity [Abstract]

Stockholder's Equity

Note 6 — Stockholder’s Equity

Common stock

— The Company is authorized to issue 100,000,000 shares of common stock with a par value of $0.0001 per share. Holders of common stock are entitled to one vote for each share held on all matters to be voted on by stockholders. As of June 30, 2020 and December 31, 2019, there were 2,875,000 shares of common stock outstanding. Of the 2,875,000 shares of common stock, an aggregate of up to 375,000 shares are subject to forfeiture to the Company by the Sponsor for no consideration to the extent that the underwriters’ over-allotment option is not exercised in full or in part, so as to maintain the number of Insider Shares at 20% of the Company’s issued and outstanding common stock after the Proposed Public Offering. On July 15, 2020, the over-allotment option was exercised in full. Accordingly, no Insider Shares were forfeited.

Warrants

— The Public Warrants may only be exercised for a whole number of shares. No fractional Public Warrants will be issued upon separation of the Units and only whole Public Warrants will trade. The Public Warrants will become exercisable on the later of (a) the completion of a Business Combination and (b) 12 months from the closing of the Proposed Public Offering; provided in each case that the Company has an effective registration statement under the Securities Act covering the issuance of the common stock issuable upon exercise of the warrants and a current prospectus relating to them is available and such shares are registered, qualified or exempt from registration under the securities, or blue sky laws of the state of residence of the holder (or the Company permits holders to exercise their warrants on a cashless basis under the circumstances specified in the warrant agreement). Notwithstanding the foregoing, if a registration statement covering the shares of common stock issuable upon exercise of the warrants is not effective within 90 days from the consummation of the initial Business Combination, warrant holders may, until such time as there is an effective registration statement and during any period when the Company has failed to maintain an effective registration statement, exercise warrants on a cashless basis pursuant to the exemption from registration provided by Section 3(a)(9) of the Securities Act provided that such exemption is available. In such event, each holder would pay the exercise price by surrendering the warrants for that number of shares of common stock equal to the quotient obtained by dividing (x) the product of the number of shares of common stock underlying the warrants, multiplied by the difference between the exercise price of the warrants and the “fair market value” (defined below) by (y) the fair market value. The “fair market value” shall mean the average reported last sale price of the shares of common stock for the 10 trading days ending on the day prior to the date of exercise.

The Company may call the Public Warrants for redemption (except with respect to the Private Placement Warrants):

•

in whole and not in part;

•

at a price of $0.01 per warrant;

•

upon a minimum of 30 days’ prior written notice of redemption;

•

a 30-trading day period

ending on the third trading day prior to the date on which the Company sends the notice of redemption to the warrant holders; and

•

if, and only if, there is a current registration statement in effect with respect to the shares of common stock underlying such warrants at the time of redemption and for the

entire 30-day trading

period referred to above and continuing each day thereafter until the date of redemption.

XML 26 R15.htm IDEA: XBRL DOCUMENT

Subsequent Events

6 Months Ended

Jun. 30, 2020

Subsequent Events [Abstract]

Subsequent Events

Note 7 — Subsequent Events

XML 27 R16.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies (Policies)

6 Months Ended

Jun. 30, 2020

Accounting Policies [Abstract]

Basis of Presentation

The accompanying unaudited condensed financial statements should be read in conjunction with the audited financial statements and notes thereto included in the Form

8-K

and the final prospectus filed by the Company with the SEC on July 21, 2020 and July 15, 2020, respectively.

Emerging Growth Company

apply to non-emerging growth companies but

Concentration of Credit Risk

Cash and Cash Equivalents

The Company considers all short-term investments with an original maturity of three months or less when purchased to be cash equivalents. The Company had no cash equivalents as of

June 30

, 2020.

Financial Instruments

Use of Estimates

Deferred Offering Costs Associated with the Initial Public Offering

Net Loss Per Share of Common Stock

Income Taxes

The provision for income taxes was deemed to be immaterial as of June 30, 2020.

Recent Accounting Standards

XML 28 R17.htm IDEA: XBRL DOCUMENT

Description of Organization and Business Operations - Additional Information (Detail) - USD ($)		6 Months Ended
	Jul. 15, 2020	Jun. 30, 2020	Dec. 31, 2019
Organisation Consolidation and Presentation of Financial Statements [Line Items]
Assets held in trust		$ 115,000,000
Common stock par value		$ 0.0001
Redemption price per share		$ 10.00
Minimum tangible assets for business combination		$ 5,000,001
Operating bank accounts		138,048	$ 180,975
working capital deficit		780,000
Proceeds from sale of founder shares		25,000
Working capital loans converted to warrants		$ 300,000
Per share value of the residual assets remaining available for distribution		10.00%
Maximum [Member]
Organisation Consolidation and Presentation of Financial Statements [Line Items]
Liquidation Cost agreed by sponsor to pay		$ 50,000
Private Placement Warrants [Member]
Organisation Consolidation and Presentation of Financial Statements [Line Items]
Number of warrants issued		6,800,000
Issue price per warrant		$ 0.50
Proceeds from issue of warrants		$ 3,400,000
IPO [Member]
Organisation Consolidation and Presentation of Financial Statements [Line Items]
Initial Public Offering, units issued	11,500,000	11,500,000
Additional units purchased which includes the full exercise by the underwriter of the over-allotment option	11,500,000	11,500,000
Initial Public Offering, price per unit	$ 10.00
Proceeds from issuance initial public offering	$ 115,000,000
Initial Public Offering, offering costs	7,300,000
Initial Public Offering, deferred underwriting commissions	$ 4,000,000
Over-Allotment Option [Member]
Organisation Consolidation and Presentation of Financial Statements [Line Items]
Initial Public Offering, units issued	1,500,000
Additional units purchased which includes the full exercise by the underwriter of the over-allotment option	1,500,000
Common Class A [Member] \| IPO [Member]
Organisation Consolidation and Presentation of Financial Statements [Line Items]
Initial Public Offering, units issued	11,500,000
Additional units purchased which includes the full exercise by the underwriter of the over-allotment option	11,500,000
Initial Public Offering, price per unit	$ 10.00
Proceeds from issuance initial public offering	$ 115,000,000
Common Class A [Member] \| Over-Allotment Option [Member]
Organisation Consolidation and Presentation of Financial Statements [Line Items]
Initial Public Offering, units issued	1,500,000
Additional units purchased which includes the full exercise by the underwriter of the over-allotment option	1,500,000

XML 29 R18.htm IDEA: XBRL DOCUMENT

Summary of Significant Accounting Policies - Additional Information (Detail)	6 Months Ended
	Jun. 30, 2020 USD ($) shares
Accounting Policies [Abstract]
Cash insured \| $	$ 250,000
Weighted average shares of common stock that are subject to forfeiture \| shares	375,000

XML 30 R19.htm IDEA: XBRL DOCUMENT

Initial Public Offering - Additional Information (Detail) - USD ($) $ / shares in Units, $ in Millions			6 Months Ended
	Jul. 15, 2020	Jun. 30, 2020	Jun. 30, 2020
Class of Warrant or Right [Line Items]
Common stock warrants exercise price per share	$ 11.50	$ 11.50	$ 11.50
Number of shares promised to hold		1,000,000
IPO [Member]
Class of Warrant or Right [Line Items]
Initial Public Offering, units issued	11,500,000		11,500,000
Stock issued during period	11,500,000		11,500,000
Initial Public Offering, price per unit	$ 10.00
Proceeds from Issuance Initial Public Offering	$ 115.0
Initial Public Offering Costs	7.3
Initial Public Offering, deferred underwriting commissions	$ 4.0
IPO [Member] \| Primerose [Member]
Class of Warrant or Right [Line Items]
Units acquired by Primerose Development Group Ltd.		1,000,000
Over-Allotment Option [Member]
Class of Warrant or Right [Line Items]
Initial Public Offering, units issued	1,500,000
Stock issued during period	1,500,000
Units acquired by Primerose Development Group Ltd.		1,500,000

XML 31 R20.htm IDEA: XBRL DOCUMENT

Related Party Transactions - Additional Information (Detail) - USD ($)				6 Months Ended
	Jul. 15, 2020	Jul. 09, 2020	Oct. 31, 2019	Jun. 30, 2020	Oct. 10, 2019
Related Party Transaction [Line Items]
Common stock par value				$ 0.0001
Number of shares forfeited				375,000
Percent of shares not transferable			50.00%
Stock price threshold limit			$ 12.50	$ 18.00
Note [Member] \| Subsequent Event [Member]
Related Party Transaction [Line Items]
Number of warrants issued	600,000
Note [Member] \| Forecast [Member]
Related Party Transaction [Line Items]
Number of warrants issued		600,000
Issue price per warrant		$ 0.50
Working Capital Loan [Member]
Related Party Transaction [Line Items]
Issue price per warrant				$ 0.50
Debt instrument face amount				$ 1,000,000
Private Placement Warrants [Member]
Related Party Transaction [Line Items]
Number of warrants issued				6,800,000
Issue price per warrant				$ 0.50
Gross proceeds from warrants				$ 3,400,000
Over-Allotment Option [Member]
Related Party Transaction [Line Items]
Stock issued during period	1,500,000
Number of shares forfeited			375,000
Sponsor [Member]
Related Party Transaction [Line Items]
Stock issued during period			2,875,000
Common stock par value			$ 0.0001
Proceeds from common stock			$ 25,000
Payment For Overhead And Administration Support				10,000
Sponsor [Member] \| Note [Member]
Related Party Transaction [Line Items]
Debt instrument face amount				$ 300,000	$ 300,000

XML 32 R21.htm IDEA: XBRL DOCUMENT

Commitments & Contingencies - Additional Information (Detail) $ / shares in Units, $ in Thousands	Jun. 30, 2020 USD ($) $ / shares shares
Subsidiary, Sale of Stock [Line Items]
Underwriting Description	(a) a lead underwriter or (b) minimally as a co-manager, with at least 30% of the economics; or, in the case of a three-handed deal 20% of the economics
Over-Allotment Option [Member]
Subsidiary, Sale of Stock [Line Items]
Sale of Stock, Number of Shares Issued in Transaction \| shares	1,500,000
IPO [Member]
Subsidiary, Sale of Stock [Line Items]
Underwriting discount per share \| $ / shares	$ 0.20
Underwriting discount \| $	$ 2,300
Deferred underwriting commissions per share \| $ / shares	$ 0.35
Deferred Underwriting Commissions \| $	$ 4,025

XML 33 R22.htm IDEA: XBRL DOCUMENT

Stockholder's Equity - Additional Information (Detail) - $ / shares	6 Months Ended
	Jun. 30, 2020	Jul. 15, 2020	Dec. 31, 2019	Oct. 31, 2019
Equity [Abstract]
Common stock shares authorized	100,000,000
Common stock par value	$ 0.0001
Common stock outstanding	2,875,000		2,875,000
Shares subject to forfeiture	375,000
Percent of number of insider shares to outstanding shares	20.00%
Class of warrant or right exercise price	$ 11.50	$ 11.50
Class of warrant or right expire period	5 years
Sale of Stock, Price Per Share	$ 9.50
Percent of gross proceeds to total equity proceeds	60.00%
Volume weighted average trading price	9.50%
Percent of exercise price of warrant to market price	115.00%
Redemption trigger price of warrant	18.00%
Percent of redemption price of warrant to market value	180.00%
Redemption price of warrant	0.01%
Stock price threshold limit	$ 18.00			$ 12.50

EXCEL 34 Financial_Report.xlsx IDEA: XBRL DOCUMENT begin 644 Financial_Report.xlsx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